Spy (XSPY) 10-K 5 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 27, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Spy Inc.
Entity Central Index Key	932372
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$4,700,000
Entity Common Stock, Shares Outstanding		13,411,044
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets
Cash	$351	$686
Accounts receivable, net	7,171	6,543
Inventories, net	7,697	5,872
Prepaid expenses and other current assets	796	680
Income taxes receivable		3
Total current assets	16,015	13,784
Property and equipment, net	509	438
Intangible assets, net of accumulated amortization of $818 and $782 at December 31, 2014 and 2013, respectively	37	72
Other long-term assets	44	63
Total assets	16,605	14,357
Liabilities and Stockholders' Deficit
Line of credit	6,775	4,024
Current portion of capital leases	73	77
Current portion of notes payable	16	16
Accounts payable	1,216	1,302
Accrued expenses and other liabilities	3,910	3,069
Total current liabilities	11,990	8,488
Capital leases, less current portion	22	92
Notes payable, less current portion		16
Note payable to stockholders	21,568	21,452
Total liabilities	33,580	30,048
Stockholders' deficit
Preferred stock: par value $0.0001; 5,000,000 authorized; none issued
Common stock: par value $0.0001; 100,000,000 shares authorized; 13,392,293 and 13,184,876 shares issued and outstanding at December 31, 2014 and 2013, respectively	1	1
Additional paid-in-capital	46,043	45,331
Accumulated other comprehensive income	450	520
Accumulated deficit	-63,469	-61,543
Total stockholders' deficit	-16,975	-15,691
Total liabilities and stockholders' deficit	$16,605	$14,357

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Current assets
Intangible assets, accumulated amortization	$818	$782
Stockholders' equity (deficit)
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	13,392,293	13,184,876
Common stock, shares outstanding	13,392,293	13,184,876

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Net sales	$38,120,000	$37,782,000
Cost of sales	18,831,000	18,921,000
Gross profit	19,289,000	18,861,000
Operating expenses:
Sales and marketing	11,506,000	11,314,000
General and administrative	5,692,000	6,112,000
Shipping and warehousing	540,000	534,000
Research and development	661,000	502,000
Total operating expenses	18,399,000	18,462,000
Income from operations	890,000	399,000
Other expense:
Interest expense	-2,500,000	-2,966,000
Foreign currency transaction loss	-138,000	-290,000
Other expense	-175,000	-5,000
Total other expense	-2,813,000	-3,261,000
Loss before provision for income taxes	-1,923,000	-2,862,000
Income tax provision	3,000
Net loss	-1,926,000	-2,862,000
Net loss per share of Common Stock
Basic and diluted	($0.14)	($0.22)
Shares used in computing net loss per share of Common Stock
Basic and diluted	13,331	13,155
Other comprehensive income (loss)
Foreign currency translation adjustment (loss) gain	703,000	-239,000
Unrealized gain (loss) on foreign currency exposure of net investment in foreign operations	-773,000	265,000
Total other comprehensive income (loss)	-70,000	26,000
Comprehensive loss	($1,996,000)	($2,836,000)

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERSb DEFICIT (USD $)	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
In Thousands, except Share data
Beginning Balance at Dec. 31, 2012	$1	$44,403	$494	($58,681)	($13,783)
Beginning Balance, Shares at Dec. 31, 2012	13,098
Shares issued to Board of Directorbs in lieu of cash payments		107			107
Shares issued to Board of Directorbs in lieu of cash payments (Shares)	77
Exercise of stock option		7			7
Exercise of stock option (Shares)	10
Share-based compensation		814			814
Share-based compensation (Shares)
Foreign currency translation adjustment			-239		-239
Unrealized gain on foreign currency exposure of net investment in foreign operations			265		265
Net loss				-2,862	-2,862
Ending Balance at Dec. 31, 2013	1	45,331	520	-61,543	-15,691
Ending Balance, Shares at Dec. 31, 2013	13,185
Shares issued to Board of Directorbs in lieu of cash payments		77			77
Shares issued to Board of Directorbs in lieu of cash payments (Shares)	68
Exercise of stock option		116			116
Exercise of stock option (Shares)	139
Share-based compensation		519			519
Share-based compensation (Shares)
Foreign currency translation adjustment			703		703
Unrealized gain on foreign currency exposure of net investment in foreign operations			-773		-773
Net loss				-1,926	-1,926
Ending Balance at Dec. 31, 2014	$1	$46,043	$450	($63,469)	($16,975)
Ending Balance, Shares at Dec. 31, 2014	13,392

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Operating Activities
Net loss	($1,926)	($2,862)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	267	312
Paid-in-kind interest		2,373
Share-based compensation	519	814
Non-cash board of directors fees	77	107
Provision for doubtful accounts	65	414
Loss on sale of property or equipment	3	9
Loss on extinguishment of debt	155
Foreign currency transaction (gain) loss	-69	26
Amortization of debt discount and premium	14	98
Change in operating assets and liabilities:
Accounts receivable, net	-693	-1,347
Inventories, net	-1,825	402
Prepaid expenses and other current assets	-165	11
Other assets	14	4
Accounts payable	-86	-156
Accrued expenses and other liabilities	841	465
Income taxes payable/receivable	3	13
Net cash (used in) provided by operating activities	-2,806	683
Investing Activities
Purchases of property and equipment	-322	-154
Proceeds from sale of property and equipment	16
Net cash used in investing activities	-306	-154
Financing Activities
Line of credit, net	2,751	-567
Principal payments on secured notes payable	-14	-15
Principal payments on notes payable to stockholders	-1
Principal payments on capital leases	-75	-86
Proceeds from exercise of stock options	116	7
Net cash provided by (used in) financing activities	2,777	-661
Net decrease in cash	-335	-132
Cash at beginning of year	686	818
Cash at end of year	351	686
Cash paid during the period for:
Interest	2,457	512
Income taxes	3	2
Summary of non-cash financing and investing activities:
Acquisition of property and equipment through capital leases		$103

Organization_and_Significant_A

Organization and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Organization and Significant Accounting Policies	Description of Business
	SPY Inc. (the “Company”) happily designs, markets and distributes premium sunglasses, goggles and prescription frame eyewear, as well as apparel and other accessories.  In 1994, the Company began as a grassroots brand in Southern California with the goal of creating innovative and aesthetically progressive eyewear, and, in doing so, the Company believes it has captured the imagination of the action sports market with authentic, distinctive, performance-driven products under the SPY® brand.  Today, the Company believes the SPY® brand, symbolized by the distinct “cross” logo, is a well recognized eyewear brand in its segment of the action sports industry, with a reputation for its high quality products, style and innovation, most notably showcased in its Happy Lens™ technology.
	The Company was incorporated as Sports Colors, Inc. in California in August 1992, but had no operations until April 1994, when the Company changed its name to Spy Optic, Inc.  In November 2004, the Company reincorporated in Delaware and changed its name to Orange 21 Inc.  In February 2012, the Company changed its name from Orange 21 Inc. to SPY Inc. to better reflect the focus of its business going forward.
	The Company operates through its subsidiaries and currently has one wholly-owned subsidiary incorporated in California, Spy Optic Inc. (“SPY North America”) and one wholly owned subsidiary incorporated in Italy, Spy Optics Europe S.r.l. S.U. (“SPY EUROPE”).
	Basis of Presentation
	The accompanying consolidated financial statements of SPY Inc. and its wholly owned subsidiaries have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. All intercompany transactions and balances have been eliminated in consolidation.
	Capital Resources
	During the year ended December 31, 2014, the Company had negative cash flow from operations principally as a result of a timing of inventory purchases and collections on accounts receivable. Although the Company had income from operations in 2013 and 2014, the Company has a history of incurring significant negative cash flow from operations, operating and net losses, and has significant working capital requirements. The Company anticipates that it will continue to have ongoing cash requirements to finance its seasonal and ongoing working capital needs and net losses.
	In order to finance the Company's working capital requirements, the Company has relied and anticipates that it will continue to rely on SPY North America’s credit line with BFI Business Finance (“BFI”) (“BFI Line of Credit”) and its credit facilities with Costa Brava Partnership III, L.P. (“Costa Brava”).  In addition, SPY North America has relied on debt and equity financing from Harlingwood (Alpha), LLC (“Harlingwood”).  Costa Brava and Harlingwood are related parties.  The total outstanding indebtedness of the Company was $28.5 million and $25.7 million at December 31, 2014 and 2013 respectively.  (See Note 6 “Short-Term Debt”, Note 7 “Long-Term Deb” and Note 13 “Related Party Transactions”)
	The Company believes it will have sufficient cash on hand and cash available under existing credit facilities to meet its operating requirements for at least the next twelve months, if the Company is able to achieve some or a combination of the following factors: (i) achieve its desired sales growth, (ii) continue the improvements in the management of working capital, and (iii) continue to manage and operate the Company at appropriate levels of sales, marketing, general and administrative, and other operating expenses in relation to overall sales.  However, the Company will need to continue to access its existing credit facilities during the next twelve months to support its planned operations and working capital requirements, and intends to (i) continue to borrow, to the extent available, from the BFI Line of Credit, (ii) if necessary, continue discretionary deferral of interest payments otherwise payable to Harlingwood, and (iii) if necessary, raise additional capital through debt or equity financings, or borrow up to the extent available on the Company’s Costa Brava Line of Credit.
	The Company does not anticipate that it can generate sufficient cash from operations to repay the amounts due under the BFI Line of Credit which is scheduled to renew in February 2016, and the borrowings from Costa Brava and Harlingwood due, as amended, on December 31, 2016, consisting of $19.8 million in borrowings from Costa Brava and $1.7 million in borrowings from Harlingwood as of December 31, 2014.  The Company will therefore need to renew the BFI Line of Credit at its annual renewal in February 2016 and continue to extend the future maturity dates of the Costa Brava and Harlingwood indebtedness. If the Company is unable to renew the BFI Line of Credit and extend future maturity dates of the Costa Brava and Harlingwood indebtedness, it will need to raise substantial additional capital through debt or equity financing to continue its operations. No assurances can be given that any such financing will be available to the Company on favorable terms, if at all. The inability to obtain debt or equity financing in a timely manner and in amounts sufficient to fund the Company’s operations, or the inability to renew the BFI Line of Credit or to extend future maturity dates of the Costa Brava and Harlingwood indebtedness, if necessary, would have an immediate and substantial adverse impact on the Company’s business, financial condition and results of operations.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Significant estimates used in preparing these consolidated financial statements include those assumed in computing allowance for doubtful accounts receivable, reserve for obsolete inventory, reserve for sales returns, assumptions used in calculating the fair value of stock options, the testing of long-lived assets for impairment and the valuation allowance on deferred tax assets. Accordingly, actual results could differ from those estimates.
	Accounts Receivable and Allowance for Doubtful Accounts
	Throughout the year, the Company performs credit evaluations on its customers, and adjusts credit limits based on payment history combined with the customer’s current creditworthiness. The Company continuously monitors its collections and maintains a reserve for estimated credits, which is calculated on a monthly basis. The Company makes judgments as to its ability to collect outstanding receivables and provide allowances for anticipated bad debts and refunds. Provisions are made based upon a review of all significant outstanding invoices and overall quality and age of those invoices not specifically reviewed.  In determining the provision for invoices not specifically reviewed, the company analyzes collection experience, customer credit worthiness and current economic trends.
	If the data used to calculate these allowances does not reflect the Company’s future ability to collect outstanding receivables, an adjustment in the reserve for refunds may be required. Historically, the Company’s losses have been consistent with its estimates, but there can be no assurance that the Company will continue to experience the same credit loss rates that it has experienced in the past. Unforeseen, material financial difficulties experienced by its customers could have an adverse impact on the Comapany’s profits.
	Inventories
	Inventories consist primarily of finished products, including sunglasses, goggles, prescription frames, apparel and accessories, product components such as replacement lenses along with purchasing and quality control costs. Inventory items are carried on the books at the lower of cost or market and the first-in first-out method for the Company’s distribution business. Periodic physical counts of inventory items are conducted to help verify the balance of inventory. A reserve is maintained for obsolete or slow moving inventory.  Products are reserved at certain percentages based on their probability of selling, which is estimated based on current and estimated future customer demand and market conditions.
	Long-Lived Assets
	Property and equipment are recorded at cost and are depreciated over the estimated useful lives of the assets (generally two to five years) using the straight-line method. Amortization of leasehold improvements is computed on the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the assets. Expenditures for repairs and maintenance are expensed as incurred. Gains and losses from the sale or retirement of property and equipment are charged to operations in the period realized or incurred.
	Intangible assets consist of trademarks and patents at December 31, 2014 and 2013, which are being amortized on a straight-line basis over 3.0 to 8.3 years. Amortization expense was approximately $35,000 and $55,000 for the years ended December 31, 2014 and 2013, respectively. Amortization expense related to intangible assets in each of the next two years is expected to be incurred as follows:
	Year Ending December 31,	(Thousands)
	2015	$	34
	2016		3
	Total	$	37
	The Company evaluates the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that such carrying values may not be recoverable. The Company estimates the future undiscounted cash flows derived from an asset to assess whether or not a potential impairment exists when events or circumstances indicate the carrying value of a long-lived asset may differ. If the sum of the undiscounted cash flows is less than the carrying value, an impairment loss will be recognized, measured as the amount by which the carrying value exceeds the fair value of the asset. The Company uses its best judgment based on the most current facts and circumstances surrounding its business when applying these impairment rules to determine the timing of the impairment test, the undiscounted cash flows used to assess impairments and the fair value of a potentially impaired asset. Changes in assumptions used could have a significant impact on the Company’s assessment of recoverability. Numerous factors, including changes in the Company’s business, industry segment or the global economy could significantly impact management’s decision to retain, dispose of or idle certain of its long-lived assets. See Note 4 “Property and Equipment”, for information regarding asset impairment charges recognized by the Company. At December 31, 2014 and 2013, no impairment of the intangible assets had occurred and the amortization periods remain appropriate.
	Point-of-Purchase Displays
	In the U.S., the cost of point-of-purchase displays is currently charged to sales and marketing expense as ownership is transferred to the customer upon shipment of the display. Displays are also sold to international distributors at which time, the sale is recognized in net sales and the cost is charged to cost of goods sold. The amount of displays sold is minimal.
	Revenue Recognition
	The Company’s revenue is primarily generated through sales of sunglasses, goggles, prescription frames, and apparel, net of returns and discounts.  Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured.  These criteria are usually met upon delivery to the Company’s “common” carrier, which is also when the risk of ownership and title passes to the Company’s customers.
	Generally, the Company extends credit to customers after performing credit evaluations and does not require collateral. The Company’s payment terms generally range from net-30 to net-90, depending on the country or whether product is sold directly to retailers or to a distributor.  The Company’s distributors are a combination of prepay and credit-term accounts. Credit may be extended to certain distributors, sometimes upon receipt of a letter of credit, credit evaluation, or use of credit insurance. Generally, the Company’s sales agreements with its customers, including distributors, do not provide for any rights of return or price protection.  However, the Company does approve returns on a case-by-case basis, at its sole discretion.  The Company records an allowance for estimated returns when revenue is recorded based on historical data and make adjustments when then Company considers it necessary.  The allowance for returns is calculated using a three step process that includes: (i) calculating an average of actual returns as a percentage of sales over a rolling twelve month period; (ii) estimating the average time period between a sale and the return of the product (13 months at December 31, 2014) and (iii) estimating the value of the product returned.  The reserve is calculated as the average return percentage times sales less discounts for the average return period less the estimated value of the product returned and adjustments are made as the Company considers necessary. Historically, actual returns have been within the Company’s expectations.  If future returns are higher than the Company’s estimates, then earnings could be adversely affected.
	Advertising
	The Company expenses advertising costs as incurred. Total advertising expense was approximately $540,000 and $394,000 for the years ended December 31, 2014 and 2013, respectively.
	Product Warranty
	The Company warrants its products for one year. The standard warranty requires the Company to replace any product or portion thereof that is deemed a manufacturer’s defect. The Company records warranty expense as incurred and records the expense in cost of sales. Based on historical evidence and future estimates, warranty expense is considered to be immaterial to the consolidated financial statements and therefore no accrual was recorded as of December 31, 2014 and December 31, 2013.
	Research and Development
	The Company expenses research and development costs as incurred.
	Shipping and Handling
	The Company records shipping and handling costs charged to customers as revenue and other shipping and handling costs to cost of sales as incurred.
	Foreign Currency
	The functional currencies of the Company’s subsidiaries, SPY North America and SPY Europe are their respective local currency. Accordingly, the Company is exposed to transaction gains and losses that could result from changes in foreign currencies. Assets and liabilities denominated in foreign currencies are translated at the rate of exchange on the balance sheet date. Revenues and expenses are translated using the average exchange rate for the period. Gains and losses from translation of foreign subsidiary financial statements are included in accumulated other comprehensive loss.
	Loss Per Share
	Basic loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is calculated by including the additional shares of common stock issuable upon exercise of outstanding options and warrants, vesting of restricted stock and the conversion of convertible debt, using the treasury stock method. The following table lists the potentially dilutive equity instruments, each convertible into one share of common stock, used in the calculation of diluted earnings per share for the periods presented:
		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Weighted average common shares outstanding—basic		13,331			13,155
	Assumed conversion of dilutive stock options, restricted stock, convertible debt and warrants		—			—
	Weighted average common shares outstanding—dilutive		13,331			13,155
	The following potentially dilutive instruments were not included in the diluted per share calculation for periods presented as their inclusion would have been antidilutive:
		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Stock options		3,139			3,091
	Warrants		244			244
	Convertible debt		4,240			2,240
	Total		7,623			5,575
	Income Taxes
	In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, the Company recorded a full valuation allowance for SPY North America and SPY EUROPE at December 31, 2014 and 2013.
	The Company may have had one or more ownership changes, as defined by Section 382 of the Internal Revenue Code (“IRC Section 382”) in previous years, and, as such, the use of its net operating losses may be limited in future years.  The Company has not completed a formal IRC Section 382 study and analysis to determine the annual limitation on the use of the net operating losses; however, the limitations could be substantial.
	Royalties
	The Company has several royalty agreements with third parties, including agreements with several athletes to use them in endorsing or advertising several of its products. Royalty expense during the years ended December 31, 2014 and 2013 was approximately $0.3 million and $0.5 million, respectively.
Comprehensive Income
Comprehensive income (loss) represents the results of operations adjusted to reflect all items recognized under accounting standards as components of comprehensive income (loss). Total comprehensive loss for the years ended December 31, 2014 and 2013 was approximately $2.0 million and $2.8 million, respectively.
The components of accumulated other comprehensive income, net of tax, are as follows:
	December 31,
	2014			2013
	(Thousands)
Equity adjustment from foreign currency translation	$	977		$	275
Unrealized (loss) gain on foreign currency exposure of net investment in foreign operations		(527	)		245
Accumulated other comprehensive income	$	450		$	520
Share-Based Compensation
The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.  Stock options generally vest annually over a three year period and the corresponding expense is ratably recognized over the same time period.  No compensation cost is recognized for equity instruments for which employees do not render the requisite service.  The grant-date fair value of employee share options and similar instruments is estimated using option-pricing models adjusted for the unique characteristics of those instruments.
Debt Modifications
From time to time, the Company has modified and also anticipates modifying certain debt agreements.  The Company has accounted for and expects to account for future changes in debt agreements as debt modifications and extinguishment of debt, where applicable, based on the relevant authoritative accounting guidance after considering the specific terms of any future debt modifications.
Recently Issued Accounting Pronouncements
In May 2014, the FASB issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The standard requires entities to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance also includes a cohesive set of disclosure requirements intended to provide users of financial statements with comprehensive information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the Company’s contracts with customers. ASU 2014-09 will be effective beginning the first quarter of the Company’s fiscal year 2017 and early application is not permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. Management is currently evaluating the effect ASU 2014-09 will have on the Company’s Consolidated Financial Statements and disclosures.
In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The Company does not intend to early adopt this standard. The adoption of this standard will not have an impact on the financial condition of the Company.

Accounts_Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Accounts Receivable	Accounts receivable consisted of the following:
		December 31,
		2014			2013
		(Thousands)
	Trade receivables	$	9,477		$	8,539
	Less allowance for doubtful accounts		(290	)		(369	)
	Less allowance for returns		(2,016	)		(1,627	)
	Accounts receivable, net	$	7,171		$	6,543

Inventories

Inventories	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following:
		December 31,
		2014		2013
		(Thousands)
	Raw materials	$	114	$	11
	Finished goods		7,583		5,861
	Inventories, net	$	7,697	$	5,872
	The Company’s balances are net of an allowance for excess and obsolete inventories of approximately $0.2 million and $0.2 million at December 31, 2014 and 2013, respectively.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consisted of the following:
		December 31,
		2014			2013
		(Thousands)
	Displays	$	—		$	73
	Molds and tooling		1,049			1,055
	Buildings and leasehold improvements		325			314
	Computer equipment and software		1,189			1,277
	Furniture and fixtures		116			132
	Vehicles		342			327
	Construction In Progress		149			—
			3,170			3,178
	Less accumulated depreciation and amortization		(2,661	)		(2,740	)
	Property and equipment, net	$	509		$	438
	There were no impairment charges during the year ended December 31, 2014 and 2013.
	Depreciation expense was approximately $0.2 million and $0.2 million for the years ended December 31, 2014 and 2013, respectively.

Accrued_Expenses_and_Other_Lia

Accrued Expenses and Other Liabilities	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accrued Expenses and Other Liabilities	Accrued expenses and other liabilities consisted of the following:
		December 31,
		2014		2013
		(Thousands)
	Compensation and benefits	$	1,396	$	671
	Production and warehouse		1,363		868
	Sales and marketing		585		678
	Commissions		240		234
	Interest		—		45
	Other		76		226
	Customers with credit balances		196		301
	Professional fees		54		46
	Total	$	3,910	$	3,069

Shortterm_Debt

Short-term Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Short-term Debt	SPY North America has a Loan and Security Agreement with BFI, originally dated February 26, 2007 and most recently modified on September 10, 2014 (the “BFI Line of Credit”). The BFI Line of Credit has a maximum borrowing limit of $8.0 million at December 31, 2014, which was increased to $9.0 million when the BFI Line of Credit was renewed in February 2015.  The maximum availability under the BFI Line of Credit was $8.0 million and $5.1 million at December 31, 2014 and 2013, respectively, of which SPY North America had borrowed $6.8 million and $4.0 million, respectively, as of those dates. The BFI Line of Credit renews annually in February for one additional year unless otherwise terminated by either SPY North America or BFI. The Company had $1.2 million and $1.1 million in unused availability as of December 31, 2014 and 2013, respectively.
	Actual borrowing availability under the BFI Line of Credit is based on eligible trade receivable and inventory levels of SPY North America. Prior to the modification on September 10, 2014 (the “Modification”), actual borrowings were subject to the following limitations: (i) up to 80% of eligible United States accounts receivable, (ii) 80% of eligible Canadian receivables, (iii) 65% of eligible United States inventory, provided, however, such amount does not exceed 65% of eligible United States and Canadian accounts receivable and does not exceed the maximum inventory borrowing amount of $3.5 million, and (iv) advances against eligible foreign accounts receivable (excluding Canadian accounts receivable) up to $0.4 million.  In connection with the Modification, actual borrowings are subject to the following limitations until February 26, 2015: (i) up to 80% of eligible United States accounts receivable, (ii) 80% of eligible Canadian receivables, (iii) 65% of eligible United States inventory, provided, however, such amount does not exceed 100% of eligible United States and Canadian accounts receivable and does not exceed the maximum inventory borrowing amount of $3.5 million, and (iv) advances against eligible foreign accounts receivable (excluding Canadian accounts receivable) up to $0.4 million. In February 2015, the Company renewed the BFI Line of Credit that resulted in the following changes: (i) increased its inventory borrowings to the lessor of $3.5 million, 100% of United States and Canadian eligible accounts receivable or 65% of eligible United States inventory, (ii) increased borrowing on eligible dating programs to 80%, and (iii) increased maximum borrowing limit of $9.0 million.
	Borrowings under the BFI Line of Credit accrue interest at a rate per annum equal to the prime rate, as reported in the Western Edition of The Wall Street Journal, plus 1.75%, with a minimum monthly interest charge of $2,000. The interest rate was 5.0% per annum at December 31, 2014. The Company and SPY North America granted BFI a security interest in substantially all of SPY North America’s assets, and substantially all of the Company’s accounts receivable and inventories to secure BFI’s position under the BFI Line of Credit.  Additionally, the obligations under the BFI Line of Credit are guaranteed by SPY Inc.
	The BFI Line of Credit imposes certain covenants on SPY North America, including, but not limited to, covenants requiring SPY North America to provide certain periodic reports to BFI, to inform BFI of certain changes in the business, to refrain from incurring additional debt in excess of $100,000 and to refrain from paying dividends.  The BFI Line of Credit also contains cross default provisions. BFI may declare SPY North America in default if SPY North America experiences a material adverse change in its business, financial condition, or in its ability to perform the obligations owed under the BFI Line of Credit.  BFI’s prior consent, which BFI will not unreasonably withhold, is required in the event that SPY North America seeks additional debt financing, including debt financing subordinate to BFI.  SPY North America has also established bank accounts in BFI’s name in the United States and Canada into which collections on accounts receivable and other collateral are deposited (the “Collateral Accounts”).  Pursuant to the deposit control account agreements between BFI and SPY North America, BFI is entitled to sweep all amounts deposited into the Collateral Accounts and apply the funds to outstanding obligations under the BFI Line of Credit; provided that BFI is required to distribute to SPY North America any amounts remaining after payment of all amounts due under the BFI Line of Credit.  SPY North America was in compliance with all covenants under the BFI Line of Credit at December 31, 2014.

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Long-term Debt	Costa Brava Term Note
	SPY North America issued a promissory note to Costa Brava in the principal amount of $7.0 million (“Costa Brava Term Note”), which amount was outstanding at each of December 31, 2014 (excluding unpaid interest related to Costa Brava Term Note, which was added to the principal balance rather than paid in cash (“Accrued PIK Interest”) of $2.1 million and unamortized debt premium of $0.1 million) and December 31, 2013 (excluding Accrued PIK Interest of $2.1 million). During the year ended December 31, 2014, approximately $0.9 million of accrued interest was paid in cash.  In April 2014, the Costa Brava Term Note was amended to: (i) extend the maturity date from April 1, 2015 to December 31, 2016, (ii) increase the amount Costa Brava may convert from $2,250,000 to $6,000,000 and reduce the conversion price from $2.25 to $2.00, (iii) reduce the interest rate from 12% to 7%, and (iv) eliminate the facility fee, effective July 1, 2014. Effective with this amendment, the Company no longer adds Accrued PIK Interest to the outstanding principal balance, and is now required to make quarterly cash interest payments (See Note 11 “Related Party Transactions”). The Company paid a final facility fee of approximately $35,000, in June 2014, which was a pro-rata portion of the annual facility fee. This amendment was accounted for as an extinguishment of debt, in accordance with authoritative guidance. In accordance with the accounting treatment of extinguishment of debt, the Company recorded expense of approximately $155,000, which represents an increase in the fair value of the Costa Brava Term Note compared to the carrying value of the Costa Brava Term Note prior to the modification. The expense associated with the modification is reported in other income and expense and the debt premium will be amortized to interest expense over the revised term of the Costa Brava Term Note. The Company also expensed approximately $16,000 in capitalized debt fees related to the previous debt agreement during 2014. The Costa Brava Term Note is subordinate to the BFI Line of Credit, pursuant to the terms of a debt subordination agreement between Costa Brava and BFI.
	Costa Brava Line of Credit
	SPY North America has an additional $9.0 million line of credit from Costa Brava (“Costa Brava Line of Credit”) of which $8.5 million was outstanding at December 31, 2014 and 2013 (excluding Accrued PIK Interest of $2.1 million during the respective periods). During the year ended December 31, 2014, approximately $1.0 million of accrued interest was paid in cash. In April of 2014, the Costa Brava Line of Credit was amended to: (i) extend the maturity date from April 1, 2015 to December 31, 2016, (ii) reduce the interest rate from 12% to 7%, and (iii) eliminate the facility fee, effective July 1, 2014. Effective with this amendment, the Company no longer adds Accrued PIK Interest to the outstanding principal, and is now required to make quarterly cash interest payments.  This amendment was accounted for as a modification of debt in accordance with authoritative guidance. The Costa Brava Line of Credit is subordinate to BFI Line of Credit, pursuant to the terms of a debt subordination agreement between Costa Brava and BFI.
	In addition, the Costa Brava Line of Credit, as amended, required SPY North America to pay a final facility fee in June, 2014 calculated as the lesser of (i) 1% of the average daily outstanding principal amount owed under the note (excluding Accrued PIK Interest) for the 365 day period ending on such payment date or (ii) $90,000. The Company has no accrued expenses and other liabilities related to facility fee as of December 31, 2014 and paid $85,000 for the required facility fee in June 2014.
	Costa Brava Loans
	As of December 31, 2014 and 2013, the Company has outstanding borrowings of $19.8 million (including $4.2 million Accrued PIK Interest and $0.1 million unamortized debt premium) and $19.7 million (including $4.2 million Accrued PIK Interest), respectively with Costa Brava.  The Costa Brava Term loan and Costa Brava Line of Credit are pari passu with respect to the rights and preferences of the Harlingwood Notes (defined below).
	Harlingwood Convertible Debt
	In 2012, SPY North America entered into convertible note purchase agreements with Harlingwood under which SPY North America issued two promissory notes to Harlingwood in the principal amounts of $1.0 million and $0.5 million (“Harlingwood Notes”).  Total outstanding borrowings under the Harlingwood Notes at December 31, 2014 and 2013 were $1.5 million (excluding Accrued PIK Interest of $0.2 million during the respective periods). During the year ended December 31, 2014, approximately $0.2 million of accrued interest was paid in cash. The Harlingwood Notes were amended in April 2014 to extend the maturity date from April 1, 2015 to December 31, 2016.  This amendment was accounted for as a modification of debt in accordance with authoritative guidance.  The Harlingwood Notes are subordinate to the amounts owed by SPY North America under the BFI Line of Credit, pursuant to the terms of a debt subordination agreement between Harlingwood and BFI. The Harlingwood Notes accrue interest at the rate of 12% per annum.
	The $1.0 million promissory note requires a facility fee equal to the lesser of $10,000 or 1% of the average daily outstanding principal amount due under the Harlingwood Notes (without giving effect to the Accrued PIK Interest).   Facility fees are due in advance on the respective anniversary date of the $1.0 million promissory note until maturity.  The $0.5 million promissory note has a facility fee of $10,000. The Company paid $10,000 to Harlingwood in September 2014 and January 2014, respectively, related to facility fees on the Harlingwood Notes.
	The principal amount due under the Harlingwood Notes (including Accrued PIK Interest) is convertible into shares of the Company’s common stock at $1.40 per share, subject to adjustment for stock splits or stock dividends.  The Harlingwood Notes contain standard representations, warranties and reporting requirements that are customary for financings of this type, and cross default provisions with respect to the Costa Brava indebtedness.  SPY North America was in compliance with all covenants under the Harlingwood Notes at December 31, 2014. The Harlingwood Notes are pari passu with the respect to the rights and preferences of the Costa Brava Term Note and Costa Brava Line of Credit. (See Note 13 “Related Party Transactions”).
	Notes payable at December 31, 2014 consist of the following:
		(Thousands)
	Costa Brava Term Loan (subordinated debt), 7% interest rate with mandatory quarterly interest payments	$	10,579
	Costa Brava Line of Credit, as amended (subordinated debt, of which up to $6.0 million is convertible into shares of common stock at a conversion price of $2.00 per share and includes $116,071 in unamortized debt premium), 7% interest rate with mandatory quarterly interest payments		9,253
	Harlingwood Notes (subordinated convertible debt, all of which is convertible into shares of common stock at a conversion price of $1.40 per share), 12% interest rate with discretionary Accrue PIK Interest		1,736
	Secured note payable for vehicle purchases, 4.69% interest rate with monthly payments of $1,400 due through December 2015, secured by vehicles		16
	Subtotal		21,584
	Less current portion		16
	Notes payable, less current portion	$	21,568
	The Costa Brava Term Note includes the $6,000,000 of principal that they may convert at their discretion, of the principal amount (excluding unpaid interest which has been added to principal) of the Costa Brava Term Note into shares of the Company’s common stock at a conversion price of $2.00 per share.
	Future minimum payments under all long-term debt agreements are as follows:
	Year ended December 31,	(Thousands)
	2015	$	16
	2016		21,568
	Total minimum debt payments	$	21,584

Stockholders_Equity_Deficit

Stockholders' Equity (Deficit)	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Stockholders' Equity (Deficit)	Common Stock
	During 2014 and 2013, an aggregate of 68,189 and 76,502 shares of common stock, respectively, were issued to individuals upon vesting of restricted stock awards. During 2014 and 2013, approximately 139,000 and 10,000 shares of common stock, respectively, were issued to individuals upon exercise of stock options.
	Shares Reserved
	The Company had 100,000,000 authorized shares of common stock at December 31, 2014. The table below outlines common shares reserved for future issuance:
		(Thousands)
	Total Authorized Shares		100,000
	Common shares issued		(13,392	)
	Shares reserved for future issuance:
	Stock options outstanding		(3,139	)
	Warrant		(244	)
	Conversion option for Costa Brava promissory note without paid in kind interest		(3,000	)
	Conversion option for Harlingwood promissory note with accrued paid in kind interest		(1,240	)
	Remaining Authorized Shares		78,985

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	The current FASB guidance provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical instruments (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:
		●	Level 1 inputs use quoted prices in active markets for identical instruments.
		●	Level 2 inputs use other inputs that are observable, either directly or indirectly. These Level 2 inputs include quoted prices for similar instruments in active markets, and other inputs such as interest rates and yield curves that are observable at commonly quoted intervals.
		●	Level 3 inputs are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related instrument.
	In instances where inputs used to measure fair value fall into different levels in the above fair value hierarchy, fair value measurements in their entirety are categorized based on the lowest level input that is significant to the valuation. The Company's assessment of the significance of particular inputs to these fair value measurements requires judgment and considers factors specific to each asset or liability.
	The Company’s financial instruments include cash, accounts receivable and payable, short-term borrowings, accrued liabilities, other short-term liabilities, capital leases, notes payable and related party notes payable.  The carrying amount of these instruments approximates fair value because of their short-term nature. The carrying value of the Company’s long-term related party notes payable approximates fair value as of December 31, 2014 and 2013.

ShareBased_Compensation

Share-Based Compensation	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Note 10. Share-Based Compensation	In December 2004, the Board of Directors of the Company adopted, and the stockholders of the Company approved, the 2014 Stock Incentive Plan, formerly the 2004 Stock Incentive Plan (the “Plan”). The Plan provides for the grant of incentive stock options to employees only, and restricted stock, stock units, nonqualified options or SARS to employees, consultants and outside directors. The Plan is administered by the Compensation Committee who determines the vesting period, exercise price and other details for each award. Following the Company’s 2014 annual meeting of stockholders on June 4. 2014, the Plan was amended and restated in order to extend the expiration date from December 7, 2014 to December 7, 2024 and to change the name of the Plan to reflect the extended term. In April 2007, in connection with a determination by the Board of Directors to reduce the annual cash compensation paid to the non-employee directors of the Company, the Board of Directors approved an amendment and restatement of the Plan that: (1) increased the number of shares of the Company’s common stock underlying the non-qualified stock options that are automatically granted to the Company’s non-employee directors upon their appointment to the Board of Directors and on an annual basis thereafter and (2) modified the vesting schedule for the automatic option grants made to non-employee directors upon their initial appointment to the Board of Directors. The amendment and restatement of the Plan was approved by the Company’s stockholders at the annual meeting held on June 12, 2007.
	Stock Option Activity
			Shares				Weighted-			Weighted-Average	Aggregate
							Average			Remaining	Intrinsic
							Exercise			Contractual	Value (Thousands)
							Price			Term (years)
	Options outstanding at December 31, 2012			2,691,633			$	1.86
	Granted			750,000			$	1.3
	Exercised			(10,000	)		$	0.65
	Expired			(81,667	)		$	1.57
	Forfeited			(259,165	)		$	1.64
	Options outstanding at December 31, 2013			3,090,801			$	1.76		6.80		493
	Granted			525,000			$	1.06
	Exercised			(139,228	)		$	0.83
	Expired			(307,407	)		$	3.08
	Forfeited			(29,998	)		$	1.37
	Options outstanding at December 31, 2014			3,139,168			$	1.56		7.13	$	3
	Options exercisable at December 31, 2014			2,180,846			$	1.72		6.33	$	2
	Information regarding stock options outstanding as of December 31, 2014 is as follows:
					Options Outstanding									Options Exercisable
	Price Range				Shares				Weighted-			Weighted-		Shares		Weighted-
									Average			Average				Average
									Exercise Price			Remaining				Exercise Price
												Contractual
												Term (years)
	$	0.71 - $0.93				355,000			$	0.88			6.75		220,000	$	0.86
	$	0.94 - $1.03				405,000			$	0.98			7.72		165,000	$	0.95
	$	1.04 - $1.24				75,000			$	1.13			9.19		18,334	$	1.16
	$	1.25				583,334			$	1.25			8.22		250,009	$	1.25
	$	1.31 - $1.41				350,000			$	1.37			8.07		240,000	$	1.36
	$	1.45 - $1.52				420,000			$	1.49			7.33		400,001	$	1.5
	$	1.60 - $1.80				460,834			$	1.7			6.58		397,502	$	1.69
	$	1.85 - $3.19				330,000			$	2.03			6.13		330,000	$	2.03
	$	3.53 - $5.95				100,000			$	4.27			2.52		100,000	$	4.27
	$	6.46				60,000			$	6.46			2.45		60,000	$	6.46
	Total					3,139,168			$	1.56			7.13		2,180,846	$	1.72
	Intrinsic value is defined as the difference between the relevant current market value of the Company’s common stock and the grant price for options with exercise prices less than the market values on such dates.  During the years ended December 31, 2014 and 2013, there were 139,000 and 10,000 stock options exercised.  The Company received cash proceeds of $116,000 and $7,000 related to the stock options exercised during the years ended December 31, 2014 and 2013, respectively.  The intrinsic value of stock options exercised was approximately $41,000 and $6,000 during the years ended December 31, 2014 and 2013, respectively.
	During the year ended December 31, 2014, the Company modified 125,000 options in connection with the resignation of a board of director. The modifications, which resulted in an extension of the term that the board member is allowed to exercise stock options, resulted in approximately $42,000 of incremental share-based compensation expense during the year ended December 31, 2014.
	During the year ended December 31, 2013, the Company modified 276,667 options in connection with the resignation of two members of the board of directors and one officer.  The modifications, which resulted in an extension of the term that the board members and officer are allowed to exercise stock options, resulted in approximately $152,000 of incremental share-based compensation expense during the year ended December 31, 2013, which excludes an offset of approximately $30,000 related to forfeited officer stock options.
	Restricted Stock Award Activity
	The Company periodically issues restricted stock awards to certain directors and key employees subject to certain vesting requirements based on future service. Fair value is calculated using the Black-Scholes option-pricing valuation model (single option approach). Although there was no restricted stock award activity during the year ended December 31, 2014, the Company did award and issue 68,189 fully vested, non-restricted shares at a $1.13 weighted-average grant date fair value, which resulted in approximately $77,000 of share-based compensation expense during year ended December 31, 2014. These shares were issued to certain members of the Company’s board of directors in lieu of cash payment for quarterly board fees.   In addition, although there was no restricted stock award activity during the year ended December 31, 2013, the Company did award and issue 76,502 fully vested non-restricted shares at a $1.40 weighted-average grant date fair value, which resulted in approximately $107,000 of share-based compensation expense during year ended December 31, 2013.
	Information regarding stock award activity is presented as follows:
			Shares			Weighted-
						Average
						Grant Date
						Fair Value
	Non-vested at December 31, 2012			—		$	—
	Awarded			76,502			1.4
	Released			(76,502	)		1.4
	Non-vested at December 31, 2013			—		$	—
	Awarded			68,189			1.13
	Released			(68,189	)		1.13
	Non-vested at December 31, 2014			—		$	—
	The Company recognized the following share-based compensation expense during the years ended December 31, 2014 and 2013:
			Year Ended
			December 31,
			2014				2013
			(Thousands)
	Stock options
	General and administrative		$	380			$	629
	Cost of sales			11				22
	Selling and marketing			115				145
	Shipping and warehousing			2				4
	Research and development			11				14
Total share-based compensation for stock options			519				814
Restricted stock
General and administrative (Board of Director’s fees in lieu of cash payments)			77				107
Total share-based compensation for restricted stock			77				107
Total share-based compensation expense			596				921
Income tax benefit (pro-forma)			(203	)			(313	)
Total share-based compensation expense, net of pro-forma income tax benefit		$	393			$	608
The Company does not expect to receive any tax benefit from the share-based compensation expense reflected above.
The following table summarizes the approximate unrecognized compensation cost for the share-based compensation awards and the weighted average remaining years over which the cost will be recognized:
		Total				Weighted
		Unrecognized				Average
		Compensation				Remaining
		Expense				Years
		(Thousands)
Total Stock options		$	417				1.68
Determining Fair Value of Stock Option Grants
Valuation and Amortization Method.    The Company uses the Black-Scholes option-pricing valuation model (single option approach) to calculate the fair value of stock option grants. For options with graded vesting, the option grant is treated as a single award and compensation cost is recognized on a straight-line basis over the vesting period of the entire award.
Expected Term.    The expected term of options granted represents the period of time that the option is expected to be outstanding. The Company estimates the expected term of the option grants based on historical exercise patterns that the Company believes to be representative of future behavior as well as other various factors.
Expected Volatility.    The Company estimates its volatility using its historical share price performance over the expected life of the options, which management believes is materially indicative of expectations about expected future volatility.
Risk-Free Interest Rate.    The Company uses risk-free interest rates in the Black-Scholes option valuation model that are based on U.S. Treasury zero-coupon issues with a remaining term equal to the expected life of the options.
Dividend Rate.    The Company has not paid dividends on its common stock and do not anticipate paying any cash dividends in the foreseeable future. Therefore, the Company uses an expected dividend yield of zero.
Forfeitures.    FASB requires companies to estimate forfeitures at the time of grant and revise those estimates in subsequent reporting periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and record share-based compensation expense only for those awards that are expected to vest.
The weighted-average estimated fair value of employee stock options granted during the years ended December 31, 2014 and 2013 was $0.65 per share and $0.98 per share, respectively. The following weighted average assumptions were used to estimate the fair value of options granted to employees and directors during the years ended December 31, 2014 and 2013:
		Year ended
		December 31,
		2014				2013
Expected volatility			85.1	%			85	%
Risk-free interest rate			1.6	%			1.3	%
Expected term (in years)			4				4
Dividend yield			—				—

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Taxes	Income tax expense attributed to income from operations consists of:
		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Current
	State	$	3		$	2
	Income tax provision	$	3		$	2
	During 2013, the state income tax expense was recorded in general and administrative expense.
	The components that comprise deferred tax assets and liabilities are as follows:
		December 31,
		2014			2013
		(Thousands)
	Deferred tax assets:
	NOL carry forwards	$	14,076		$	13,848
	Allowance for doubtful accounts		116			147
	Compensation and vacation accrual		123			165
	Reserve for returns and allowances		803			648
	Unrealized foreign currency loss		31			47
	Inventory reserve		85			94
	Foreign deferred tax asset before valuation allowance		2,204			2,213
	Non-cash compensation		1,508			1,434
	Depreciation and amortization		408			447
	Benefit of state tax items		1			1
	Capital loss on sale of LEM		4,294			4,294
	Other		285			88
	Net deferred tax asset before valuation allowance		23,934			23,426
	Valuation allowance		(23,934	)		(23,426	)
	Net deferred tax liability	$	—		$	—
	The reconciliation of computed “expected” income taxes to effective income tax expense by applying the federal statutory rate of 34% is as follows:
		Year Ending
		December 31,
		2014			2013
		(Thousands)
	Computed “expected” tax expense	$	(643	)	$	(1,006	)
	State taxes, net of federal benefit		(109	)		(171	)
	Permanent items		31			30
	U.S. valuation allowances		723			1,150
	Other, net		1			(1	)
	Income tax expense	$	3		$	2
	In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, the Company has recorded a full valuation allowance of $23.9 million and $23.4 million for its worldwide operations at December 31, 2014 and 2013, respectively. The change in the valuation allowance for the years ended December 31, 2014 and 2013 was an increase of $0.5 million and $1.7 million, respectively. The Company has recorded a $21.7 million and $21.2 million valuation allowance for SPY North America at December 31, 2014 and 2013, respectively. The Company has recorded a $2.2 million and $2.2 million valuation allowance for SPY Europe at December 31, 2014 and 2013, respectively. For federal and California income tax purposes, capital losses may only offset capital gains, with any excess capital losses available for carry-back to the previous three tax years and carry-forward for a five year period.  The company has not done an IRS section 382 study, and therefore its ability to utilize income tax loss carry forwards may be limited.

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Employee Benefit Plans	In 1998, the Company adopted the Spy Optic Inc. 401(k) Plan (“401(k) Plan”).  The 401(k) Plan covers all employees who meet the eligibility requirements of a minimum of 3 months of service and 18 years of age. The 401(k) Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974. Under the provisions of the 401(k) Plan, eligible participants may contribute up to 15% of their annual compensation, not to exceed the maximum legal deferral. The Company is not required to contribute to the 401(k) Plan and made no contributions to the 401(k) Plan during the years ended December 31, 2014 or 2013.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions	Promissory Notes with Shareholder, Costa Brava
	See Note 7 “Long-Term Debt” to the Consolidated Financial Statements regarding promissory notes held by Costa Brava, an entity that owned, at December 31, 2014, approximately 47.3%, or 57.0% on an as converted basis, of the Company’s common stock. The Chairman of the Company’s Board of Directors, Mr. Seth Hamot, is the President and sole member of Roark, Rearden & Hamot, LLC which is the sole general partner of Costa Brava. As of December 31, 2014, Mr. Hamot owns approximately 48.7% or 58.1% on a converted basis, of the Company’s common stock.
	As of December 31, 2014 and 2013, the Company has outstanding borrowings of $19.8 million (including $4.2 million Accrued PIK Interest and $0.1 unamortized debt premium) and $19.7 million (including $4.2 million Accrued PIK Interest), respectively with Costa Brava.
	Convertible Notes with Shareholder, Harlingwood
	See Note 7 “Long-Term Debt” to the Consolidated Financial Statements regarding $1.5 million in total promissory notes held by Harlingwood, an entity that owned, at December 31, 2014 approximately 5.3%, or 13.3% on an as converted basis, of the Company’s common stock. Mr. Fir Geenen, a member of the Company’s Board of Directors, manages Harlingwood.
	The total outstanding borrowings under all promissory notes issued by the Company to Harlingwood at December 31, 2014 and December 31, 2013 was $1.7 million (including $0.2 million Accrued PIK Interest), respectively.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Operating Leases
	The Company’s corporate headquarters totals 32,551 square feet and is located in Carlsbad, California.  Effective November 2010, the Company entered into an amended lease for this facility with average monthly rent payments of approximately $29,000 per month.  In April 2013, the Company amended its lease to (i) extend the expiration date to December 31, 2019, and (ii) give the Company the right to terminate the lease commencing on April 1, 2015 with nine months notice.  The monthly rent payments after 2014 will increase by 3% per year. Effective August 2014, the Company entered into a five-year lease agreement to rent approximately 1,200 square feet of office and retail space in Encinitas, CA. Monthly base rent is $5,700, subject to annual 3% increases.
	The Company also leased approximately 6,500 square feet of a facility in Varese, Italy with monthly lease payments effective March 2013 of €1,500 per month. On March 10, 2014, the Company elected to terminate its lease in Italy, effective September 10, 2014. In addition, the Company leases an office space totaling approximately 400 square feet in Vancouver, Canada at a monthly rate of CAD 1,295 (approximately $1,161).  The Company also leases certain computer equipment and vehicles.
	Total rent expense was approximately $436,000 and $413,000 for the years ended December 31, 2014 and 2013, respectively.
	Future minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year are as follows:
	Year Ending December 31,	(Thousands)
	2015	$	441
	2016		448
	2017		461
	2018		475
	2019		458
	Thereafter		—
	Total	$	2,283
	Capital Leases
	Future minimum lease payments under capital leases at December 31, 2014 are as follows:
	Year Ending December 31,	(Thousands)
	2015	$	76
	2016		23
	Total minimum lease payments		99
	Amount representing interest		(4	)
	Present value of minimum lease payments		95
	Less current portion		73
	Long-term portion	$	22
	The cost of equipment under a capital lease at December 31, 2014 and 2013 was approximately $267,000 and $231,000, respectively. The amount of accumulated depreciation related to equipment under capital lease at December 31, 2014 and 2013 was approximately $227,000 and $156,000, respectively. Amortization of assets held under capital leases is included in depreciation expense.
	Athlete Contracts
	At December 31, 2014, the Company has entered into endorsement contracts with athletes to actively wear and endorse the Company’s products. These contracts are based on minimum annual payments totaling approximately $453,000, $319,000, and $7,000, in 2015, 2016, and 2017, respectively, and may include additional performance-based incentives and/or product-specific sales incentives. At December 31, 2014, the Company also had in-process endorsement contracts with athletes to actively wear and endorse the Company’s products with minimum annual payments totaling approximately $145,000.
	Litigation
	From time to time the Company may be party to lawsuits in the ordinary course of business. The Company is not currently a party to any material legal proceedings which it believes will have a material adverse impact on its financial position.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentrations	Credit Risk
	Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company grants unsecured credit to substantially all of its customers. Management does not believe that it is exposed to any extraordinary credit risk as a result of this policy.
	The Company maintains cash balances at various financial institutions primarily located in San Diego and in Italy. Accounts at the U.S. institutions are secured by the Federal Deposit Insurance Corporation. The Company has not experienced any losses in such accounts. Management believes that the Company is not exposed to any significant credit risk with respect to its cash.
	Customer
	For the year ended December 31, 2014, the Company had sales to one third party customer that accounted for 10% or more of total net sales and none during the year ended December 31, 2013.
	Supplier
	During 2014 and 2013, the Company purchased the majority of its sunglass products from several manufacturers in China and one in Italy. During 2014 and 2013, the vast majority of the Company’s goggle products were manufactured by OGK in China. Additionally, the Company’s Happy Lens™ is currently supplied by two manufactures in France and China. The Company does not have long-term agreements with any of its manufacturers. The Company believes that other suppliers could provide plastic frames on comparable terms; however, a change in suppliers could result in a delay in manufacturing and a possible loss of sales, which would adversely affect operating results.

Operating_Segments_and_Geograp

Operating Segments and Geographic Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Operating Segments and Geographic Information	Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Company’s management in deciding how to allocate resources and in assessing performance.  The Company designs, produces and distributes sunglasses, snow and motocross goggles, prescription frames, along with branded apparel and accessories for the action sports, snow sports and lifestyle markets.
	The Company markets its products in North America and internationally.  Revenue is attributed to the location to which the product is shipped.  Beginning on January 1, 2013, substantially all sales to international customers were made by SPY North America.  During and prior to 2012, substantially all sales to international customers were made by SPY Europe.  Identifiable assets are based on location of domicile:
	Year Ended December 31, (Thousands)	U.S. and		Europe, Asia Pacific		Consolidated
		Canada		and Latin America
	Net sales 2013	$	32,614	$	5,168	$	37,782
	Net sales 2014	$	31,816	$	6,304	$	38,120
		December 31,
		2014		2013
		(Thousands)
	Tangible long-lived assets:
	U.S. and Canada	$	509	$	438
	Europe,  Asia Pacific and Latin America		—		—
	Total	$	509	$	438

Quarterly_Financial_Data

Quarterly Financial Data	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Data		First			Second			Third			Fourth
		Quarter			Quarter			Quarter			Quarter
		(Thousands, except per share data)
	Year ended December 31, 2014:
	Net sales	$	9,192		$	8,183		$	10,977		$	9,768
	Gross profit		4,780			4,542			5,398			4,569
	Income from operations		84			101			593			112
	Loss before provision for income taxes		(739	)		(742	)		(19	)		(423	)
	Net loss		(742	)		(742	)		(19	)		(423	)
	Basic and diluted net loss per share	$	(0.06	)	$	(0.06	)	$	(0.00	)	$	(0.03	)
	Year ended December 31, 2013:
	Net sales	$	9,008		$	9,995		$	10,152		$	8,627
	Gross profit		4,407			5,277			4,927			4,056
	Income (loss) from operations		29			327			454			(411	)
	Loss before provision for income taxes		(721	)		(574	)		(302	)		(1,265	)
	Net loss		(721	)		(574	)		(302	)		(1,265	)
	Basic and diluted net loss per share	$	(0.05	)	$	(0.04	)	$	(0.02	)	$	(0.10	)

Schedule_IIValuation_and_Quali

Schedule IIbValuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule IIbValuation and Qualifying Accounts	SPY Inc. and Subsidiaries
	Schedule II—Valuation and Qualifying Accounts
	For the Years Ended December 31, 2014 and 2013
		Balance at		Additions		Deductions			Balance at
		Beginning							End of Year
		of Year
		(Thousands)
	Allowance for doubtful accounts:
	Year ended December 31, 2014	$	369	$	65	$	(144	)	$	290
	Year ended December 31, 2013	$	305	$	406	$	(342	)	$	369
	Allowance for sales returns:
	Year ended December 31, 2014	$	1,627	$	389	$	—		$	2,016
	Year ended December 31, 2013	$	1,572	$	116	$	(61	)	$	1,627
	Allowance for inventory reserve:
	Year ended December 31, 2014	$	236	$	74	$	(97	)	$	213
	Year ended December 31, 2013	$	626	$	114	$	(504	)	$	236
	Note: Additions to the allowance for doubtful accounts are charged to bad debt expense which is recorded in sales and marketing or general and administrative expense. Additions to the allowance for sales returns are charged against revenue. Additions to the allowance for inventory reserve are charged against cost of goods sold.
	All other schedules have been omitted because they are either inapplicable or the required information has been provided in the Consolidated Financial Statements or the Notes thereto.

Organization_and_Significant_A1

Organization and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Description of Business	SPY Inc. (the “Company”) happily designs, markets and distributes premium sunglasses, goggles and prescription frame eyewear, as well as apparel and other accessories.  In 1994, the Company began as a grassroots brand in Southern California with the goal of creating innovative and aesthetically progressive eyewear, and, in doing so, the Company believes it has captured the imagination of the action sports market with authentic, distinctive, performance-driven products under the SPY® brand.  Today, the Company believes the SPY® brand, symbolized by the distinct “cross” logo, is a well recognized eyewear brand in its segment of the action sports industry, with a reputation for its high quality products, style and innovation, most notably showcased in its Happy Lens™ technology.
	The Company was incorporated as Sports Colors, Inc. in California in August 1992, but had no operations until April 1994, when the Company changed its name to Spy Optic, Inc.  In November 2004, the Company reincorporated in Delaware and changed its name to Orange 21 Inc.  In February 2012, the Company changed its name from Orange 21 Inc. to SPY Inc. to better reflect the focus of its business going forward.
	The Company operates through its subsidiaries and currently has one wholly-owned subsidiary incorporated in California, Spy Optic Inc. (“SPY North America”) and one wholly owned subsidiary incorporated in Italy, Spy Optics Europe S.r.l. S.U. (“SPY EUROPE”).
Basis of Presentation	The accompanying consolidated financial statements of SPY Inc. and its wholly owned subsidiaries have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. All intercompany transactions and balances have been eliminated in consolidation.
Capital Resources	During the year ended December 31, 2014, the Company had negative cash flow from operations principally as a result of a timing of inventory purchases and collections on accounts receivable. Although the Company had income from operations in 2013 and 2014, the Company has a history of incurring significant negative cash flow from operations, operating and net losses, and has significant working capital requirements. The Company anticipates that it will continue to have ongoing cash requirements to finance its seasonal and ongoing working capital needs and net losses.
	In order to finance the Company's working capital requirements, the Company has relied and anticipates that it will continue to rely on SPY North America’s credit line with BFI Business Finance (“BFI”) (“BFI Line of Credit”) and its credit facilities with Costa Brava Partnership III, L.P. (“Costa Brava”).  In addition, SPY North America has relied on debt and equity financing from Harlingwood (Alpha), LLC (“Harlingwood”).  Costa Brava and Harlingwood are related parties.  The total outstanding indebtedness of the Company was $28.5 million and $25.7 million at December 31, 2014 and 2013 respectively.  (See Note 6 “Short-Term Debt”, Note 7 “Long-Term Deb” and Note 13 “Related Party Transactions”)
	The Company believes it will have sufficient cash on hand and cash available under existing credit facilities to meet its operating requirements for at least the next twelve months, if the Company is able to achieve some or a combination of the following factors: (i) achieve its desired sales growth, (ii) continue the improvements in the management of working capital, and (iii) continue to manage and operate the Company at appropriate levels of sales, marketing, general and administrative, and other operating expenses in relation to overall sales.  However, the Company will need to continue to access its existing credit facilities during the next twelve months to support its planned operations and working capital requirements, and intends to (i) continue to borrow, to the extent available, from the BFI Line of Credit, (ii) if necessary, continue discretionary deferral of interest payments otherwise payable to Harlingwood, and (iii) if necessary, raise additional capital through debt or equity financings, or borrow up to the extent available on the Company’s Costa Brava Line of Credit.
	The Company does not anticipate that it can generate sufficient cash from operations to repay the amounts due under the BFI Line of Credit which is scheduled to renew in February 2016, and the borrowings from Costa Brava and Harlingwood due, as amended, on December 31, 2016, consisting of $19.8 million in borrowings from Costa Brava and $1.7 million in borrowings from Harlingwood as of December 31, 2014.  The Company will therefore need to renew the BFI Line of Credit at its annual renewal in February 2016 and continue to extend the future maturity dates of the Costa Brava and Harlingwood indebtedness. If the Company is unable to renew the BFI Line of Credit and extend future maturity dates of the Costa Brava and Harlingwood indebtedness, it will need to raise substantial additional capital through debt or equity financing to continue its operations. No assurances can be given that any such financing will be available to the Company on favorable terms, if at all. The inability to obtain debt or equity financing in a timely manner and in amounts sufficient to fund the Company’s operations, or the inability to renew the BFI Line of Credit or to extend future maturity dates of the Costa Brava and Harlingwood indebtedness, if necessary, would have an immediate and substantial adverse impact on the Company’s business, financial condition and results of operations.
Use of Estimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Significant estimates used in preparing these consolidated financial statements include those assumed in computing allowance for doubtful accounts receivable, reserve for obsolete inventory, reserve for sales returns, assumptions used in calculating the fair value of stock options, the testing of long-lived assets for impairment and the valuation allowance on deferred tax assets. Accordingly, actual results could differ from those estimates.
Accounts Receivable, Reserve for Refunds and Returns and Allowance for Doubtful Accounts	Throughout the year, the Company performs credit evaluations on its customers, and adjusts credit limits based on payment history combined with the customer’s current creditworthiness. The Company continuously monitors its collections and maintains a reserve for estimated credits, which is calculated on a monthly basis. The Company makes judgments as to its ability to collect outstanding receivables and provide allowances for anticipated bad debts and refunds. Provisions are made based upon a review of all significant outstanding invoices and overall quality and age of those invoices not specifically reviewed.  In determining the provision for invoices not specifically reviewed, the company analyzes collection experience, customer credit worthiness and current economic trends.
	If the data used to calculate these allowances does not reflect the Company’s future ability to collect outstanding receivables, an adjustment in the reserve for refunds may be required. Historically, the Company’s losses have been consistent with its estimates, but there can be no assurance that the Company will continue to experience the same credit loss rates that it has experienced in the past. Unforeseen, material financial difficulties experienced by its customers could have an adverse impact on the Comapany’s profits.
Inventories	Inventories consist primarily of finished products, including sunglasses, goggles, prescription frames, apparel and accessories, product components such as replacement lenses along with purchasing and quality control costs. Inventory items are carried on the books at the lower of cost or market and the first-in first-out method for the Company’s distribution business. Periodic physical counts of inventory items are conducted to help verify the balance of inventory. A reserve is maintained for obsolete or slow moving inventory.  Products are reserved at certain percentages based on their probability of selling, which is estimated based on current and estimated future customer demand and market conditions.
Long-Lived Assets	Property and equipment are recorded at cost and are depreciated over the estimated useful lives of the assets (generally two to five years) using the straight-line method. Amortization of leasehold improvements is computed on the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the assets. Expenditures for repairs and maintenance are expensed as incurred. Gains and losses from the sale or retirement of property and equipment are charged to operations in the period realized or incurred.
	Intangible assets consist of trademarks and patents at December 31, 2014 and 2013, which are being amortized on a straight-line basis over 3.0 to 8.3 years. Amortization expense was approximately $35,000 and $55,000 for the years ended December 31, 2014 and 2013, respectively. Amortization expense related to intangible assets in each of the next two years is expected to be incurred as follows:
	Year Ending December 31,	(Thousands)
	2015	$	34
	2016		3
	Total	$	37
	The Company evaluates the carrying value of long-lived assets for impairment whenever events or changes in circumstances indicate that such carrying values may not be recoverable. The Company estimates the future undiscounted cash flows derived from an asset to assess whether or not a potential impairment exists when events or circumstances indicate the carrying value of a long-lived asset may differ. If the sum of the undiscounted cash flows is less than the carrying value, an impairment loss will be recognized, measured as the amount by which the carrying value exceeds the fair value of the asset. The Company uses its best judgment based on the most current facts and circumstances surrounding its business when applying these impairment rules to determine the timing of the impairment test, the undiscounted cash flows used to assess impairments and the fair value of a potentially impaired asset. Changes in assumptions used could have a significant impact on the Company’s assessment of recoverability. Numerous factors, including changes in the Company’s business, industry segment or the global economy could significantly impact management’s decision to retain, dispose of or idle certain of its long-lived assets. See Note 4 “Property and Equipment”, for information regarding asset impairment charges recognized by the Company. At December 31, 2014 and 2013, no impairment of the intangible assets had occurred and the amortization periods remain appropriate.
Point-of-Purchase Displays	In the U.S., the cost of point-of-purchase displays is currently charged to sales and marketing expense as ownership is transferred to the customer upon shipment of the display. Displays are also sold to international distributors at which time, the sale is recognized in net sales and the cost is charged to cost of goods sold. The amount of displays sold is minimal.
Revenue Recognition	The Company’s revenue is primarily generated through sales of sunglasses, goggles, prescription frames, and apparel, net of returns and discounts.  Revenue from product sales is recognized when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured.  These criteria are usually met upon delivery to the Company’s “common” carrier, which is also when the risk of ownership and title passes to the Company’s customers.
	Generally, the Company extends credit to customers after performing credit evaluations and does not require collateral. The Company’s payment terms generally range from net-30 to net-90, depending on the country or whether product is sold directly to retailers or to a distributor.  The Company’s distributors are a combination of prepay and credit-term accounts. Credit may be extended to certain distributors, sometimes upon receipt of a letter of credit, credit evaluation, or use of credit insurance. Generally, the Company’s sales agreements with its customers, including distributors, do not provide for any rights of return or price protection.  However, the Company does approve returns on a case-by-case basis, at its sole discretion.  The Company records an allowance for estimated returns when revenue is recorded based on historical data and make adjustments when then Company considers it necessary.  The allowance for returns is calculated using a three step process that includes: (i) calculating an average of actual returns as a percentage of sales over a rolling twelve month period; (ii) estimating the average time period between a sale and the return of the product (13 months at December 31, 2014) and (iii) estimating the value of the product returned.  The reserve is calculated as the average return percentage times sales less discounts for the average return period less the estimated value of the product returned and adjustments are made as the Company considers necessary. Historically, actual returns have been within the Company’s expectations.  If future returns are higher than the Company’s estimates, then earnings could be adversely affected.
Advertising	The Company expenses advertising costs as incurred. Total advertising expense was approximately $540,000 and $394,000 for the years ended December 31, 2014 and 2013, respectively.
Product Warranty	The Company warrants its products for one year. The standard warranty requires the Company to replace any product or portion thereof that is deemed a manufacturer’s defect. The Company records warranty expense as incurred and records the expense in cost of sales. Based on historical evidence and future estimates, warranty expense is considered to be immaterial to the consolidated financial statements and therefore no accrual was recorded as of December 31, 2014 and December 31, 2013.
Research and Development	The Company expenses research and development costs as incurred.
Shipping and Handling	The Company records shipping and handling costs charged to customers as revenue and other shipping and handling costs to cost of sales as incurred.
Foreign Currency	The functional currencies of the Company’s subsidiaries, SPY North America and SPY Europe are their respective local currency. Accordingly, the Company is exposed to transaction gains and losses that could result from changes in foreign currencies. Assets and liabilities denominated in foreign currencies are translated at the rate of exchange on the balance sheet date. Revenues and expenses are translated using the average exchange rate for the period. Gains and losses from translation of foreign subsidiary financial statements are included in accumulated other comprehensive loss.
Loss Per Share	Basic loss per share is computed by dividing net income or loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share is calculated by including the additional shares of common stock issuable upon exercise of outstanding options and warrants, vesting of restricted stock and the conversion of convertible debt, using the treasury stock method. The following table lists the potentially dilutive equity instruments, each convertible into one share of common stock, used in the calculation of diluted earnings per share for the periods presented:
		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Weighted average common shares outstanding—basic		13,331			13,155
	Assumed conversion of dilutive stock options, restricted stock, convertible debt and warrants		—			—
	Weighted average common shares outstanding—dilutive		13,331			13,155
	The following potentially dilutive instruments were not included in the diluted per share calculation for periods presented as their inclusion would have been antidilutive:
		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Stock options		3,139			3,091
	Warrants		244			244
	Convertible debt		4,240			2,240
	Total		7,623			5,575
Income Taxes	In assessing the realization of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based on the level of historical operating results and the uncertainty of the economic conditions, the Company recorded a full valuation allowance for SPY North America and SPY EUROPE at December 31, 2014 and 2013.
	The Company may have had one or more ownership changes, as defined by Section 382 of the Internal Revenue Code (“IRC Section 382”) in previous years, and, as such, the use of its net operating losses may be limited in future years.  The Company has not completed a formal IRC Section 382 study and analysis to determine the annual limitation on the use of the net operating losses; however, the limitations could be substantial.
Royalties	The Company has several royalty agreements with third parties, including agreements with several athletes to use them in endorsing or advertising several of its products. Royalty expense during the years ended December 31, 2014 and 2013 was approximately $0.3 million and $0.5 million, respectively.
Comprehensive Income (Loss)	Comprehensive income (loss) represents the results of operations adjusted to reflect all items recognized under accounting standards as components of comprehensive income (loss). Total comprehensive loss for the years ended December 31, 2014 and 2013 was approximately $2.0 million and $2.8 million, respectively.
	The components of accumulated other comprehensive income, net of tax, are as follows:
		December 31,
		2014			2013
		(Thousands)
	Equity adjustment from foreign currency translation	$	977		$	275
	Unrealized (loss) gain on foreign currency exposure of net investment in foreign operations		(527	)		245
	Accumulated other comprehensive income	$	450		$	520
Share-Based Compensation	The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.  Stock options generally vest annually over a three year period and the corresponding expense is ratably recognized over the same time period.  No compensation cost is recognized for equity instruments for which employees do not render the requisite service.  The grant-date fair value of employee share options and similar instruments is estimated using option-pricing models adjusted for the unique characteristics of those instruments.
Debt Modifications	From time to time, the Company has modified and also anticipates modifying certain debt agreements.  The Company has accounted for and expects to account for future changes in debt agreements as debt modifications and extinguishment of debt, where applicable, based on the relevant authoritative accounting guidance after considering the specific terms of any future debt modifications.
Recently Issued Accounting Pronouncements	In May 2014, the FASB issued Accounting Standard Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The standard requires entities to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance also includes a cohesive set of disclosure requirements intended to provide users of financial statements with comprehensive information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from the Company’s contracts with customers. ASU 2014-09 will be effective beginning the first quarter of the Company’s fiscal year 2017 and early application is not permitted. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. Management is currently evaluating the effect ASU 2014-09 will have on the Company’s Consolidated Financial Statements and disclosures.
	In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, which is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The Company does not intend to early adopt this standard. The adoption of this standard will not have an impact on the financial condition of the Company.

Organization_and_Significant_A2

Organization and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Amortization expense related to intangible assets	Year Ending December 31,	(Thousands)
	2015	$	34
	2016		3
	Total	$	37
Calculation of diluted earnings per share		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Weighted average common shares outstanding—basic		13,331			13,155
	Assumed conversion of dilutive stock options, restricted stock, convertible debt and warrants		—			—
	Weighted average common shares outstanding—dilutive		13,331			13,155
Dilutive instruments not included in the diluted per share		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Stock options		3,139			3,091
	Warrants		244			244
	Convertible debt		4,240			2,240
	Total		7,623			5,575
Components of accumulated other comprehensive income, net of tax		December 31,
		2014			2013
		(Thousands)
	Equity adjustment from foreign currency translation	$	977		$	275
	Unrealized (loss) gain on foreign currency exposure of net investment in foreign operations		(527	)		245
	Accumulated other comprehensive income	$	450		$	520

Accounts_Receivable_Tables

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2014
Receivables [Abstract]
Accounts receivable		December 31,
		2014			2013
		(Thousands)
	Trade receivables	$	9,477		$	8,539
	Less allowance for doubtful accounts		(290	)		(369	)
	Less allowance for returns		(2,016	)		(1,627	)
	Accounts receivable, net	$	7,171		$	6,543

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventories		December 31,
		2014		2013
		(Thousands)
	Raw materials	$	114	$	11
	Finished goods		7,583		5,861
	Inventories, net	$	7,697	$	5,872

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property and equipment		December 31,
		2014			2013
		(Thousands)
	Displays	$	—		$	73
	Molds and tooling		1,049			1,055
	Buildings and leasehold improvements		325			314
	Computer equipment and software		1,189			1,277
	Furniture and fixtures		116			132
	Vehicles		342			327
	Construction In Progress		149			—
			3,170			3,178
	Less accumulated depreciation and amortization		(2,661	)		(2,740	)
	Property and equipment, net	$	509		$	438

Accrued_Expenses_and_Other_Lia1

Accrued Expenses and Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accrued expenses and other liabilities		December 31,
		2014		2013
		(Thousands)
	Compensation and benefits	$	1,396	$	671
	Production and warehouse		1,363		868
	Sales and marketing		585		678
	Commissions		240		234
	Interest		—		45
	Other		76		226
	Customers with credit balances		196		301
	Professional fees		54		46
	Total	$	3,910	$	3,069

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Notes payable		(Thousands)
	Costa Brava Term Loan (subordinated debt), 7% interest rate with mandatory quarterly interest payments	$	10,579
	Costa Brava Line of Credit, as amended (subordinated debt, of which up to $6.0 million is convertible into shares of common stock at a conversion price of $2.00 per share and includes $116,071 in unamortized debt premium), 7% interest rate with mandatory quarterly interest payments		9,253
	Harlingwood Notes (subordinated convertible debt, all of which is convertible into shares of common stock at a conversion price of $1.40 per share), 12% interest rate with discretionary Accrue PIK Interest		1,736
	Secured note payable for vehicle purchases, 4.69% interest rate with monthly payments of $1,400 due through December 2015, secured by vehicles		16
	Subtotal		21,584
	Less current portion		16
	Notes payable, less current portion	$	21,568
Future minimum payments under all long-term debt agreements	Year ended December 31,	(Thousands)
	2015	$	16
	2016		21,568
	Total minimum debt payments	$	21,584

Stockholders_Equity_Deficit_Ta

Stockholders' Equity (Deficit) (Tables)	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Schedule of common shares reserved for future issuance		(Thousands)
	Total Authorized Shares		100,000
	Common shares issued		(13,392	)
	Shares reserved for future issuance:
	Stock options outstanding		(3,139	)
	Warrant		(244	)
	Conversion option for Costa Brava promissory note without paid in kind interest		(3,000	)
	Conversion option for Harlingwood promissory note with accrued paid in kind interest		(1,240	)
	Remaining Authorized Shares		78,985

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Option Activity			Shares				Weighted-			Weighted-Average	Aggregate
							Average			Remaining	Intrinsic
							Exercise			Contractual	Value (Thousands)
							Price			Term (years)
	Options outstanding at December 31, 2012			2,691,633			$	1.86
	Granted			750,000			$	1.3
	Exercised			(10,000	)		$	0.65
	Expired			(81,667	)		$	1.57
	Forfeited			(259,165	)		$	1.64
	Options outstanding at December 31, 2013			3,090,801			$	1.76		6.80		493
	Granted			525,000			$	1.06
	Exercised			(139,228	)		$	0.83
	Expired			(307,407	)		$	3.08
	Forfeited			(29,998	)		$	1.37
	Options outstanding at December 31, 2014			3,139,168			$	1.56		7.13	$	3
	Options exercisable at December 31, 2014			2,180,846			$	1.72		6.33	$	2
Stock options outstanding					Options Outstanding									Options Exercisable
	Price Range				Shares				Weighted-			Weighted-		Shares		Weighted-
									Average			Average				Average
									Exercise Price			Remaining				Exercise Price
												Contractual
												Term (years)
	$	0.71 - $0.93				355,000			$	0.88			6.75		220,000	$	0.86
	$	0.94 - $1.03				405,000			$	0.98			7.72		165,000	$	0.95
	$	1.04 - $1.24				75,000			$	1.13			9.19		18,334	$	1.16
	$	1.25				583,334			$	1.25			8.22		250,009	$	1.25
	$	1.31 - $1.41				350,000			$	1.37			8.07		240,000	$	1.36
	$	1.45 - $1.52				420,000			$	1.49			7.33		400,001	$	1.5
	$	1.60 - $1.80				460,834			$	1.7			6.58		397,502	$	1.69
	$	1.85 - $3.19				330,000			$	2.03			6.13		330,000	$	2.03
	$	3.53 - $5.95				100,000			$	4.27			2.52		100,000	$	4.27
	$	6.46				60,000			$	6.46			2.45		60,000	$	6.46
	Total					3,139,168			$	1.56			7.13		2,180,846	$	1.72
Information regarding stock award activity			Shares			Weighted-
						Average
						Grant Date
						Fair Value
	Non-vested at December 31, 2012			—		$	—
	Awarded			76,502			1.4
	Released			(76,502	)		1.4
	Non-vested at December 31, 2013			—		$	—
	Awarded			68,189			1.13
	Released			(68,189	)		1.13
	Non-vested at December 31, 2014			—		$	—
Stock-based compensation expense			Year Ended
			December 31,
			2014				2013
			(Thousands)
	Stock options
	General and administrative		$	380			$	629
	Cost of sales			11				22
	Selling and marketing			115				145
	Shipping and warehousing			2				4
	Research and development			11				14
	Total share-based compensation for stock options			519				814
	Restricted stock
	General and administrative (Board of Director’s fees in lieu of cash payments)			77				107
	Total share-based compensation for restricted stock			77				107
	Total share-based compensation expense			596				921
	Income tax benefit (pro-forma)			(203	)			(313	)
	Total share-based compensation expense, net of pro-forma income tax benefit		$	393			$	608
Unrecognized compensation cost			Total				Weighted
			Unrecognized				Average
			Compensation				Remaining
			Expense				Years
			(Thousands)
	Total Stock options		$	417				1.68
Weighted average assumptions			Year ended
			December 31,
			2014				2013
	Expected volatility			85.1	%			85	%
	Risk-free interest rate			1.6	%			1.3	%
	Expected term (in years)			4				4
	Dividend yield			—				—

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income tax expense		Year Ended
		December 31,
		2014			2013
		(Thousands)
	Current
	State	$	3		$	2
	Income tax provision	$	3		$	2
Components that comprise deferred tax assets and liabilities		December 31,
		2014			2013
		(Thousands)
	Deferred tax assets:
	NOL carry forwards	$	14,076		$	13,848
	Allowance for doubtful accounts		116			147
	Compensation and vacation accrual		123			165
	Reserve for returns and allowances		803			648
	Unrealized foreign currency loss		31			47
	Inventory reserve		85			94
	Foreign deferred tax asset before valuation allowance		2,204			2,213
	Non-cash compensation		1,508			1,434
	Depreciation and amortization		408			447
	Benefit of state tax items		1			1
	Capital loss on sale of LEM		4,294			4,294
	Other		285			88
	Net deferred tax asset before valuation allowance		23,934			23,426
	Valuation allowance		(23,934	)		(23,426	)
	Net deferred tax liability	$	—		$	—
Reconciliation of computed expected income taxes		Year Ending
		December 31,
		2014			2013
		(Thousands)
	Computed “expected” tax expense	$	(643	)	$	(1,006	)
	State taxes, net of federal benefit		(109	)		(171	)
	Permanent items		31			30
	U.S. valuation allowances		723			1,150
	Other, net		1			(1	)
	Income tax expense	$	3		$	2

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year	Year Ending December 31,	(Thousands)
	2015	$	441
	2016		448
	2017		461
	2018		475
	2019		458
	Thereafter		—
	Total	$	2,283
Future minimum lease payments under capital leases	Year Ending December 31,	(Thousands)
	2015	$	76
	2016		23
	Total minimum lease payments		99
	Amount representing interest		(4	)
	Present value of minimum lease payments		95
	Less current portion		73
	Long-term portion	$	22

Operating_Segments_and_Geograp1

Operating Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Summary of net sales by major geographic region	Year Ended December 31, (Thousands)	U.S. and		Europe, Asia Pacific		Consolidated
		Canada		and Latin America
	Net sales 2013	$	32,614	$	5,168	$	37,782
	Net sales 2014	$	31,816	$	6,304	$	38,120
Summary of tangible long-lived assets by major geographic region		December 31,
		2014		2013
		(Thousands)
	Tangible long-lived assets:
	U.S. and Canada	$	509	$	438
	Europe,  Asia Pacific and Latin America		—		—
	Total	$	509	$	438

Quarterly_Financial_Data_Table

Quarterly Financial Data (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Data		First			Second			Third			Fourth
		Quarter			Quarter			Quarter			Quarter
		(Thousands, except per share data)
	Year ended December 31, 2014:
	Net sales	$	9,192		$	8,183		$	10,977		$	9,768
	Gross profit		4,780			4,542			5,398			4,569
	Income from operations		84			101			593			112
	Loss before provision for income taxes		(739	)		(742	)		(19	)		(423	)
	Net loss		(742	)		(742	)		(19	)		(423	)
	Basic and diluted net loss per share	$	(0.06	)	$	(0.06	)	$	(0.00	)	$	(0.03	)
	Year ended December 31, 2013:
	Net sales	$	9,008		$	9,995		$	10,152		$	8,627
	Gross profit		4,407			5,277			4,927			4,056
	Income (loss) from operations		29			327			454			(411	)
	Loss before provision for income taxes		(721	)		(574	)		(302	)		(1,265	)
	Net loss		(721	)		(574	)		(302	)		(1,265	)
	Basic and diluted net loss per share	$	(0.05	)	$	(0.04	)	$	(0.02	)	$	(0.10	)

Schedule_IIValuation_and_Quali1

Schedule IIbValuation and Qualifying Accounts (Tables)	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Valuation and Qualifying Accounts	Schedule II—Valuation and Qualifying Accounts
	For the Years Ended December 31, 2014 and 2013
		Balance at		Additions		Deductions			Balance at
		Beginning							End of Year
		of Year
		(Thousands)
	Allowance for doubtful accounts:
	Year ended December 31, 2014	$	369	$	65	$	(144	)	$	290
	Year ended December 31, 2013	$	305	$	406	$	(342	)	$	369
	Allowance for sales returns:
	Year ended December 31, 2014	$	1,627	$	389	$	—		$	2,016
	Year ended December 31, 2013	$	1,572	$	116	$	(61	)	$	1,627
	Allowance for inventory reserve:
	Year ended December 31, 2014	$	236	$	74	$	(97	)	$	213
	Year ended December 31, 2013	$	626	$	114	$	(504	)	$	236

Organization_and_Significant_A3

Organization and Significant Accounting Policies (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Year Ending December 31,
2015	$34
2016	3
Intangible Assets	$37

Organization_and_Significant_A4

Organization and Significant Accounting Policies (Details 1)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Calculation of diluted earnings per share
Weighted average common shares outstanding - basic	13,331	13,155
Assumed conversion of dilutive stock options, restricted stock, convertible debt and warrants
Weighted average common shares outstanding - dilutive	13,331	13,155

Organization_and_Significant_A5

Organization and Significant Accounting Policies (Details 2)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Dilutive instruments not included in the diluted per share
Antidilutive securities excluded from computation of Earnings Per Share	7,623	5,575
Stock Options [Member]
Dilutive instruments not included in the diluted per share
Antidilutive securities excluded from computation of Earnings Per Share	3,139	3,091
Warrant [Member]
Dilutive instruments not included in the diluted per share
Antidilutive securities excluded from computation of Earnings Per Share	244	244
Convertible Debt [Member]
Dilutive instruments not included in the diluted per share
Antidilutive securities excluded from computation of Earnings Per Share	4,240	2,240

Organization_and_Significant_A6

Organization and Significant Accounting Policies (Details 3) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Components of accumulated other comprehensive income, net of tax
Equity adjustment from foreign currency translation	$977	$275
Unrealized (loss) gain on foreign currency exposure of net investment in foreign operations	-527	-245
Accumulated other comprehensive income	$450	$520

Organization_and_Significant_A7

Organization and Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Debt outstanding to related parties	$28,500,000	$25,700,000
Amortization expense	35,000	55,000
Impairment charges	0	0
Advertising expense	540,000	394,000
Royalty expense	300,000	500,000
Comprehensive loss	-1,996,000	-2,836,000
Harlingwood [Member]
Aggregate original principal borrowings	1,700,000
Costa Brava [Member]
Aggregate original principal borrowings	$19,800,000
MininumMember
Amortization as straight line method	P3Y
MaximumMember
Amortization as straight line method	P8Y3M18D

Accounts_Receivable_Details

Accounts Receivable (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accounts receivable
Trade receivables	$9,477	$8,539
Less allowance for doubtful accounts	-290	-369
Less allowance for returns	-2,016	-1,627
Accounts receivable, net	$7,171	$6,543

Inventories_Details

Inventories (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventories
Raw materials	$114	$11
Finished goods	7,583	5,861
Inventories, net	$7,697	$5,872

Inventories_Details_Narrative

Inventories (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Inventories (Textual) [Abstract]
Inventory Valuation Reserves	$200,000	$200,000

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property and equipment, Gross	$3,170	$3,178
Less accumulated depreciation and amortization	-2,661	-2,740
Property and equipment, net	509	438
Displays [Member]
Property and equipment, Gross		73
Molds and Tooling [Member]
Property and equipment, Gross	1,049	1,055
Buildings and Leasehold Improvements [Member]
Property and equipment, Gross	325	314
Computer Equipment and Software [Member]
Property and equipment, Gross	1,189	1,277
Furniture and Fixtures [Member]
Property and equipment, Gross	116	132
Vehicles [Member]
Property and equipment, Gross	342	327
Construction in Progress [Member]
Property and equipment, Gross	$149

Property_and_Equipment_Details1

Property and Equipment (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property And Equipment Details Narrative
Impairment charges	$0	$0
Depreciation expense	$200,000	$200,000

Accrued_Expenses_and_Other_Lia2

Accrued Expenses and Other Liabilities (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accrued expenses and other liabilities	$3,910	$3,069
Compensation and benefits [Member]
Accrued expenses and other liabilities	1,396	671
Production and warehouse [Member]
Accrued expenses and other liabilities	1,363	868
Sales and marketing [Member]
Accrued expenses and other liabilities	585	678
Commissions [Member]
Accrued expenses and other liabilities	240	234
Interest [Member]
Accrued expenses and other liabilities		45
Other [Member]
Accrued expenses and other liabilities	76	226
Customers with credit balances [Member]
Accrued expenses and other liabilities	196	301
Professional fees [Member]
Accrued expenses and other liabilities	$54	$46

Shortterm_Debt_Details_Narrati

Short-term Debt (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 01, 2015	Feb. 01, 2013
Line of Credit Facility [Line Items]
Outstanding borrowings	$6,775,000	$4,024,000
BFI [Member]
Line of Credit Facility [Line Items]
Maximum borrowing limit	8,000,000		9,000,000
Maximum availability	8,000,000	5,100,000
Outstanding borrowings	6,800,000	4,000,000
Credit line renewal period	1 year
Unused borrowing availability	1,200,000	1,100,000
Interest rate	5.00%
Monthly interest charge	2,000
Prime rate plus	1.75%
Maximum additional debt permitted	100,000
AccountsReceivable [Member]
Line of Credit Facility [Line Items]
Eligible availability			80.00%
AccountsReceivable [Member] | US
Line of Credit Facility [Line Items]
Eligible availability	80.00%
AccountsReceivable [Member] | Canada
Line of Credit Facility [Line Items]
Eligible availability	80.00%			80.00%
Inventory [Member]
Line of Credit Facility [Line Items]
Maximum borrowing limit			3,500,000
Maximum availability			400,000
Eligible availability			65.00%
Inventory [Member] | US
Line of Credit Facility [Line Items]
Maximum borrowing limit	3,500,000
Maximum availability	$400,000
Eligible availability	65.00%

LongTerm_Debt_Details

Long-Term Debt (Details) (USD $)	Dec. 31, 2014
Notes payable
Secured note payable for vehicle purchases, 4.69% interest rate with monthly payments of $1,400 due through December 2015, secured by vehicles	$16,000
Subtotal	21,584,000
Less current portion	16,000
Notes payable, less current portion	21,568,000
Costa Brava [Member]
Notes payable
Subordinated convertible debt	10,579,000
Line of Credit (subordinated debt)	9,253,000
Harlingwood [Member]
Notes payable
Subordinated convertible debt	$1,736,000

LongTerm_Debt_Details_1

Long-Term Debt (Details 1) (USD $)	Dec. 31, 2014
Long-Term Debt Details 1
2014	$16,000
2015	21,568,000
Total minimum debt payments	$21,584,000

Longterm_Debt_Details_Narrativ

Long-term Debt (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Debt Instrument [Line Items]
Accrued Interest	$3,910,000	$3,069,000
Extinguishment of debt expense	155,000
Costa Brava [Member]
Debt Instrument [Line Items]
Unamortized debt premium	100,000
Percentage of ownership by shareholder, on converted basis	57.00%
Outstanding borrowings of promissory notes	19,800,000	19,700,000
Accrued Interest	4,200,000	4,200,000
Costa Brava [Member] | Line of Credit [Member]
Debt Instrument [Line Items]
Repayment of interest	1,000,000
Interest rate	7.00%	12.00%
Facility fee interest rate	1.00%
Facility fee	85,000
Agreed facility fee maximum		90,000
Line of credit maximum borrowing capacity	9,000,000
Line of credit, amount outstanding	8,500,000	8,500,000
LOC accrued interest	2,100,000	2,100,000
Costa Brava [Member] | Note [Member]
Debt Instrument [Line Items]
Initial note amount	7,000,000
Promissory note, amount outstanding	7,000,000
Accrued Interest	2,100,000
Unamortized debt premium	100,000
Repayment of interest	900,000
Interest rate	7.00%	12.00%
Facility fee	35,000
Extinguishment of debt expense	155,000
Capitalized debt fees	16,000
Convertible principal	6,000,000	2,250,000
Conversion price	$2	$2.25
Harlingwood [Member]
Debt Instrument [Line Items]
Promissory note, amount outstanding	1,500,000
Accrued Interest	200,000
Repayment of interest	200,000
Interest rate	12.00%
Facility fee interest rate	1.00%
Facility fee	10,000
Percentage of ownership by shareholder, on converted basis	13.30%
Conversion price	$1.40
Outstanding borrowings of promissory notes	1,736,000
Accrued Interest	200,000	200,000
Harlingwood [Member] | Note Payable (1) [Member]
Debt Instrument [Line Items]
Initial note amount	1,000,000
Agreed facility fee maximum	10,000
Harlingwood [Member] | Note Payable (2) [Member]
Debt Instrument [Line Items]
Initial note amount	500,000
Accrued expenses and other liabilities related to facility fee	10,000
Agreed facility fee maximum	$10,000

Stockholders_Equity_Deficit_De

Stockholders Equity (Deficit) (Details)	Dec. 31, 2014
Stockholders Equity Deficit Details
Total Authorized Shares	100,000
Common shares issued	-13,392
Shares reserved for future issuance:
Stock options outstanding	-3,139
Warrant	-244
Conversion option for Costa Brava promissory note without paid in kind interest	-300
Conversion option for Harlingwood promissory note with accrued paid in kind interest	-1,240
Remaining Authorized Shares	78,985

Stockholders_Equity_Deficit_De1

Stockholders Equity (Deficit) (Details Narrative)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Common stock Shares authorized	100,000
Restricted Stock [Member]
Shares issued upon vesting of restricted stock awards	68,189	76,502
EmployeeStockOptionMember
Shares issued upon exercise of stock options	139,000	10,000

ShareBased_Compensation_Detail

Share-Based Compensation (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Stock Option Activity
Stock options outstanding, Beginning balance	3,090,801	2,691,633
Stock options, Shares, Granted	525,000	750,000
Stock options, Shares, Exercised	-139,228	-10,000
Stock options, Shares, Expired	-307,407	-81,667
Stock options, Shares, Forfeited	-29,998	-259,165
Stock options outstanding, Ending balance	3,139,168	3,090,801
Stock options exercisable	2,180,846
Weighted Average Exercise Price
Weighted Average Exercise Price, Stock options outstanding, Beginning balance	$1.76	$1.86
Stock options Granted, Weighted Average Exercise Price	$1.06	$1.30
Stock options Exercised, Weighted Average Exercise Price	$0.83	$0.65
Stock options Expired, Weighted Average Exercise Price	$3.08	$1.57
Stock options Forfeited, Weighted Average Exercise Price	$1.37	$1.64
Weighted Average Exercise Price, Stock options outstanding, Ending balance	$1.56	$1.76
Stock options Exercised, Weighted Average Exercise Price	$1.72
Weighted Average Remaining Contractual Term
Stock options outstanding, Weighted Average Remaining Contractual Term		6 years 9 months 18 days
Stock options exercisable, Weighted Average Remaining Contractual Term		7 years 1 month 7 days
Aggregate Intrinsic Value
Stock options outstanding, Aggregate Intrinsic Value	$3	$493
Stock options exercisable, Aggregate Intrinsic Value	$2

ShareBased_Compensation_Detail1

Share-Based Compensation (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014
Options Outstanding
Shares	3,139,168
Weighted Average Exercise Price	$1.56
Weighted Average Remaining Contractual Term (years)	7 years 1 month 17 days
Options Exercisable
Shares	2,180,846
Weighted Average Exercise Price	$1.72
Range One [Member]
Options Outstanding
Shares	355,000
Weighted Average Exercise Price	$0.88
Weighted Average Remaining Contractual Term (years)	6 years 9 months 0 days
Options Exercisable
Shares	220,000
Weighted Average Exercise Price	$0.86
RangeTwoMember
Options Outstanding
Shares	405,000
Weighted Average Exercise Price	$0.98
Weighted Average Remaining Contractual Term (years)	7 years 8 months 19 days
Options Exercisable
Shares	220,000
Weighted Average Exercise Price	$0.86
RangeThree Member
Options Outstanding
Shares	75,000
Weighted Average Exercise Price	$1.13
Weighted Average Remaining Contractual Term (years)	9 years 2 months 9 days
Options Exercisable
Shares	165,000
Weighted Average Exercise Price	$0.95
RangeFourMember
Options Outstanding
Price Range	$1.25
Shares	583,334
Weighted Average Exercise Price	$1.25
Weighted Average Remaining Contractual Term (years)	8 years 2 months 19 days
Options Exercisable
Shares	18,334
Weighted Average Exercise Price	$1.16
RangeFiveMember
Options Outstanding
Shares	350,000
Weighted Average Exercise Price	$1.37
Weighted Average Remaining Contractual Term (years)	8 years 0 months 26 days
Options Exercisable
Shares	250,009
Weighted Average Exercise Price	$1.25
RangeSixMember
Options Outstanding
Shares	420,000
Weighted Average Exercise Price	$1.49
Weighted Average Remaining Contractual Term (years)	7 years 3 months 29 days
Options Exercisable
Shares	400,001
Weighted Average Exercise Price	$1.50
RangeSevenMember
Options Outstanding
Shares	460,834
Weighted Average Exercise Price	$1.70
Weighted Average Remaining Contractual Term (years)	6 years 6 months 29 days
Options Exercisable
Shares	397,502
Weighted Average Exercise Price	$1.69
RangeEightMember
Options Outstanding
Shares	330,000
Weighted Average Exercise Price	$2.03
Weighted Average Remaining Contractual Term (years)	6 years 1 month 17 days
Options Exercisable
Shares	330,000
Weighted Average Exercise Price	$2.03
Range Nine [Member]
Options Outstanding
Shares	100,000
Weighted Average Exercise Price	$4.27
Weighted Average Remaining Contractual Term (years)	2 years 6 months 7 days
Options Exercisable
Shares	100,000
Weighted Average Exercise Price	$4.27
Range Ten [Member]
Options Outstanding
Price Range	$6.46
Shares	60,000
Weighted Average Exercise Price	$6.46
Weighted Average Remaining Contractual Term (years)	2 years 5 months 12 days
Options Exercisable
Shares	60,000
Weighted Average Exercise Price	$6.46
MininumMember | Range One [Member]
Options Outstanding
Price Range	$0.71
MininumMember | RangeTwoMember
Options Outstanding
Price Range	$0.94
MininumMember | RangeThree Member
Options Outstanding
Price Range	$1.04
MininumMember | RangeFiveMember
Options Outstanding
Price Range	$1.31
MininumMember | RangeSixMember
Options Outstanding
Price Range	$1.45
MininumMember | RangeSevenMember
Options Outstanding
Price Range	$1.60
MininumMember | RangeEightMember
Options Outstanding
Price Range	$1.85
MininumMember | Range Nine [Member]
Options Outstanding
Price Range	$3.53
MaximumMember | Range One [Member]
Options Outstanding
Price Range	$0.93
MaximumMember | RangeTwoMember
Options Outstanding
Price Range	$1.03
MaximumMember | RangeThree Member
Options Outstanding
Price Range	$1.24
MaximumMember | RangeFiveMember
Options Outstanding
Price Range	$1.41
MaximumMember | RangeSixMember
Options Outstanding
Price Range	$1.52
MaximumMember | RangeSevenMember
Options Outstanding
Price Range	$1.80
MaximumMember | RangeEightMember
Options Outstanding
Price Range	$3.19
MaximumMember | Range Nine [Member]
Options Outstanding
Price Range	$5.95

ShareBased_Compensation_Detail2

Share-Based Compensation (Details 2) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-Based Compensation Details 2
Non Vested Shares beginning Balance
Non Vested Shares Awarded	68,189	76,502
Non Vested Shares Released	-68,189	-76,502
Non Vested Shares Ending Balance
Weighted-Average Grant Date Fair Value Beginning Balance
Weighted-Average Grant Date Fair Value Awarded	$1.13	$1.40
Weighted-Average Grant Date Fair Value Released	$1.13	$1.40
Weighted-Average Grant Date Fair Value Ending Balance

ShareBased_Compensation_Detail3

Share-Based Compensation (Details 3) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Research and development	$661,000	$502,000
Share-based compensation expense	596,000	921,000
Income tax benefit (pro-forma)	-203,000	313,000
Stock-based compensation expense, net of pro-forma income tax benefit	393,000	608,000
Stock Options [Member]
General and administrative	380,000	629,000
Cost of sales	11,000	22,000
Selling and marketing	115,000	145,000
Shipping and warehousing	2,000	4,000
Research and development	11,000	14,000
Share-based compensation expense	519,000	814,000
Restricted Stock [Member]
General and administrative	77,000	107,000
Share-based compensation expense	$77,000	$107,000

ShareBased_Compensation_Detail4

Share-Based Compensation (Details 4) (Stock Options [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Stock Options [Member]
Total Unrecognized Compensation Expense	$417
Weighted Average Remaining Years	1 year 8 months 4 days

ShareBased_Compensation_Detail5

Share-Based Compensation (Details 5) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-Based Compensation Details 5
Expected volatility	85.10%	85.00%
Risk-free interest rate	1.60%	1.30%
Expected term (in years)	4 years	4 years
Dividend yield

ShareBased_Compensation_Detail6

Share-Based Compensation (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash proceeds from the exercise of stock options	$116,000	$7,000
Options forfeited	-29,998	-259,165
Share-based compensation expense	596,000	921,000
Stock Options [Member]
Options exercised	139,000	10,000
Cash proceeds from the exercise of stock options	116,000	7,000
Intrinsic value of stock options exercised	$41,000	$6,000
Modified Option	125,000	276,667
Incremental share-based compensation expense Options Excercised	42,000	152,000
Options forfeited		-30,000
Share-based compensation expense	519,000	814,000
Fair Value of Stock Option Grants [Member]
Weighted-average grant date fair value	$0.65	$0.98
Restricted Stock [Member]
Restrcited shares issued	68,189	76,502
Weighted-average grant date fair value	$1.13	$1.40
Share-based compensation expense	$77,000	$107,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current
State	$3	$2
Income tax provision	$3	$2

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets:
NOL carry forwards	$14,076	$13,848
Allowance for doubtful accounts	116	147
Compensation and vacation accrual	123	165
Reserve for returns and allowances	803	648
Unrealized foreign currency loss	31	47
Inventory reserve	85	94
Foreign deferred tax asset before valuation allowance	2,204	2,213
Non-cash compensation	1,508	1,434
Depreciation and amortization	408	447
Benefit of state tax items	1	1
Capital loss on sale of LEM	4,294	4,294
Other	285	88
Net deferred tax asset before valuation allowance	23,934	23,426
Valuation allowance	-23,934	-23,426
Net deferred tax liability

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Computed expected tax expense	($643)	($1,006)
State taxes, net of federal benefit	-109	-171
Permanent items	31	30
U.S. valuation allowances	723	1,150
Other, net	1	-1
Income tax provision	$3	$2

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Federal statutory rate	34.00%
Valuation allowance	$23,934,000	$23,426,000
Change in valuation allowance	500,000	1,700,000
Subsidiaries [Member] | US and Canada [Member]
Valuation allowances	21,700,000	21,200,000
Subsidiaries [Member] | Europe [Member]
Valuation allowances	$2,200,000	$2,200,000

Employee_Benefit_Plans_Details

Employee Benefit Plans (Details Narrative)	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent	15.00%

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Related Party Transactions (Textual) [Abstract]
Outstanding borrowings of promissory notes	($16,000)
Long-term Debt	21,584,000
Costa Brava [Member]
Related Party Transactions (Textual) [Abstract]
Percentage of Common stock owned	47.30%	57.00%
Percentage of Common stock owned on converted basis	57.00%
Outstanding borrowings of promissory notes	19,800,000	19,700,000
Accrued Interest	4,200,000	4,200,000
Unamortized debt premium	100,000
Costa Brava [Member] | Board of Directors Chairman [Member]
Related Party Transactions (Textual) [Abstract]
Percentage of Common stock owned	48.70%
Percentage of Common stock owned on converted basis	58.10%
Harlingwood [Member]
Related Party Transactions (Textual) [Abstract]
Percentage of Common stock owned	5.30%
Percentage of Common stock owned on converted basis	13.30%
Outstanding borrowings of promissory notes	1,700,000	1,700,000
Accrued Interest	200,000	200,000
Long-term Debt	$1,500,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of one year
2015	$441
2016	448
2017	461
2018	475
2019	458
Thereafter
Total	$2,283

Commitments_and_Contingencies_2

Commitments and Contingencies (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Future minimum lease payments under capital leases
2015	$76
2016	23
Total minimum lease payments	99
Amount representing interest	-4
Present value of minimum lease payments	95
Less current portion	73	77
Long-term portion	$22	$92

Commitments_and_Contingencies_3

Commitments and Contingencies (Details Narrative) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Total rent expense	$436,000	$445,000
Equipment lease	267,000	231,000
Accumulated depreciation, equipment lease	227,000	156,000
Endorsement [Member]
Minimum annual contracts payments due in 2015	453,000
Minimum annual contracts payments due in 2016	319,000
Minimum annual contracts payments due in 2017	7,000
Minimum annual contracts payments due in 2018	7,000
Endorsement 2 [Member]
Minimum annual contracts payments due in 2015	145,000
Canada CA Dollars [Member]
Monthly rent payments	1,295
CA
Monthly rent payments	29,000
Monthly interest rate increase	3.00%
Canada
Monthly rent payments	1,161
Canada | Encinatas [Member]
Monthly rent payments	5,700
Monthly interest rate increase	3.00%
Italy
Monthly rent payments	$1,500

Concentrations_Details_Narrati

Concentrations (Details Narrative)	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration risk	Sales to one third party customer
Concentration Risk percentage	10.00%

Operating_Segments_and_Geograp2

Operating Segments and Geographic Information (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Geographic Areas, Revenues from External Customers
Net sales	$37,782	$38,120
US and Canada [Member]
Geographic Areas, Revenues from External Customers
Net sales	32,614	31,816
EuropeAndAsiaPacific [Member]
Geographic Areas, Revenues from External Customers
Net sales	$5,168	$6,304

Operating_Segments_and_Geograp3

Operating Segments and Geographic Information (Details 1) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Summary of tangible long-lived assets by major geographic region
Tangible long-lived assets	$509	$438
US and Canada [Member]
Summary of tangible long-lived assets by major geographic region
Tangible long-lived assets	509	438
EuropeAndAsiaPacific [Member]
Summary of tangible long-lived assets by major geographic region
Tangible long-lived assets

Quarterly_Financial_Data_unaud

Quarterly Financial Data (unaudited) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Data Details
Net sales	$9,768	$10,977	$8,183	$9,192	$8,627	$10,152	$9,995	$9,008	$38,120	$37,782
Gross profit	4,569	5,398	4,542	4,780	4,056	4,927	5,277	4,407	19,289	18,861
Income (loss) from operations	112	593	101	84	411	454	327	29	-890	-399
Loss before provision for income taxes	-423	-19	-742	-739	-1,265	-302	-574	-721	-1,923	-2,862
Net loss	($423)	($19)	($742)	($742)	($1,265)	($302)	($574)	($721)	($1,926)	($2,862)
Basic and diluted net loss per share	($0.03)	$0	($0.06)	($0.06)	($0.10)	($0.02)	($0.04)	($0.05)	($0.14)	($0.22)

Schedule_IIValuation_and_Quali2

Schedule IIbValuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Allowance for doubtful accounts [Member]
Balance at Beginning of Year	$369	$305
Additions	65	406
Deductions	-144	-342
Balance at End of Year	290	369
Allowance for inventory reserve [Member]
Balance at Beginning of Year	1,627	1,572
Additions	389	116
Deductions		-61
Balance at End of Year	2,016	1,627
Allowance for sales returns [Member]
Balance at Beginning of Year	236	626
Additions	74	114
Deductions	-97	-504
Balance at End of Year	$213	$236